Tag Archives: Patent

China’s 15th Five-Year Plan Science and Technology Import Tax Incentives 2026: How Foreign R&D Centres Qualify

  • China’s Notice on Import Tax Incentives for Science and Technology during the 15th Five-Year Plan (Caiguanshui [2026] No. 7) exempts eligible institutions from import duty, import VAT and consumption tax on scientific research, technology development and teaching supplies that cannot be produced domestically or whose performance cannot meet requirements.
    中国《关于”十五五”期间支持科技创新进口税收优惠政策的通知》(财关税〔2026〕7 号)规定,对符合条件的机构进口国内不能生产或性能不能满足需要的科学研究、科技开发和教学用品,免征进口关税和进口环节增值税、消费税。
  • Foreign-invested R&D centres are expressly listed as the seventh of 13 categories of eligible entities, and are approved by the provincial commerce department together with the provincial finance and tax authorities and the local directly subordinate customs.
    外资研发中心被明确列为 13 类适用主体中的第(七)类,由省级商务主管部门会同省级财政、税务部门和所在地直属海关核定。
  • The lower half-year application window runs from 1 October to 25 October each year, with approval results released by 30 November.
    每年下半年申报窗口为 10 月 1 日至 10 月 25 日,核定结果于 11 月 30 日前发布。
  • Exempt goods are subject to list management: the list of duty-free imports is drawn up separately by the Ministry of Finance together with relevant departments, so the exemption is not automatic.
    免税进口商品实行清单管理,免税进口商品清单由财政部会同有关部门另行制定印发,因此该优惠并非自动享受。
  • A foreign-invested R&D centre that is not an independent legal person can also apply, submitting the business licence of the foreign-invested enterprise it relies on and a list of R&D investment assets.
    非独立法人的外资研发中心同样可以申报,需提交其所依托外商投资企业的营业执照以及研发总投入资产清单。

China’s 15th Five-Year Plan Science and Technology Import Tax Incentives 2026: How Foreign R&D Centres Qualify | “十五五”期间支持科技创新进口税收优惠政策 2026:外资研发中心如何符合条件

Overview

The Ministry of Finance and other departments have issued the Notice on Import Tax Incentives for Science and Technology during the 15th Five-Year Plan (Caiguanshui [2026] No. 7). The notice was made public through channels including the Anhui Regulatory Bureau of the Ministry of Finance on 12 October 2026.

The notice grants import tax exemptions to a defined set of research, education and publication institutions. Article 1 provides that scientific research institutions, technology development institutions, schools, Party schools (academies of governance) and libraries are exempt from import duty and import-stage value-added tax and consumption tax on scientific research, technology development and teaching supplies that cannot be produced domestically or whose performance cannot meet requirements. Article 2 provides that publication import units importing books and materials for scientific research and teaching for the institutions above are exempt from import-stage value-added tax.

Foreign-invested R&D centres are among the eligible entities. This article sets out the scope of the notice, the position of foreign-invested R&D centres within it, the list management requirement, and the practical steps and timing for an application.

Key developments in 2026

Thirteen categories of eligible entities

Article 3 lists the entities to which the policy applies. They are:

  1. Central, provincial and prefecture-level research institutes engaged in scientific research, and their graduate schools and libraries with independent legal person status;
  2. National laboratories and national laboratory bases;
  3. National key laboratories, national emerging industry innovation centres, national manufacturing innovation centres, national technology innovation centres, national clinical medical research centres, national industrial technology engineering centres, national university science parks, Belt and Road joint laboratories, national major science and technology infrastructure, national science and technology resource sharing platforms, and national field scientific observation and research stations;
  4. Institutions that became enterprises or entered enterprises during the reform of the science and technology system and mainly engage in scientific research and technology development;
  5. National small and medium-sized enterprise public service demonstration platforms (technology category);
  6. Enterprise technology centres recognised by the National Development and Reform Commission;
  7. Foreign-invested R&D centres approved by the provincial commerce department together with the provincial finance and tax authorities and the local directly subordinate customs;
  8. Science and technology private non-enterprise units recognised by the Ministry of Science and Technology together with the Ministry of Civil Affairs, and new-type R&D institutions of the science and technology private non-enterprise unit category approved by the provincial science and technology department together with the provincial civil affairs, finance and tax authorities and the local directly subordinate customs;
  9. Public institution-type new R&D institutions approved by the provincial science and technology department together with the provincial finance and tax authorities and the local directly subordinate customs;
  10. Higher education institutions recognised by the State that provide junior college education or above, and their branch campuses and off-site teaching institutions with independent legal person status;
  11. Party schools (academies of governance) at county level and above;
  12. Public libraries at prefecture level and above;
  13. Publication import units with publication import permits recognised by the Central Propaganda Department.

List management: the exemption is not automatic

Article 4 provides that exempt imported goods are subject to list management, and that the list of duty-free imported goods is drawn up and issued separately by the Ministry of Finance together with relevant departments. Two consequences follow: meeting the entity test is not the end of the analysis, because the specific goods must fall within the list; and because the list is issued separately, the operative scope of the exemption is set by that document rather than by the notice alone.

Article 1 also contains a substantive condition on the goods: the exemption applies to supplies that cannot be produced domestically or whose performance cannot meet requirements.

The supporting administrative measures

The Ministry of Finance, the Central Propaganda Department, the National Development and Reform Commission, the Ministry of Education, the Ministry of Science and Technology, the Ministry of Industry and Information Technology, the Ministry of Civil Affairs, the Ministry of Commerce, the Ministry of Culture and Tourism, the National Health Commission, the General Administration of Customs and the State Taxation Administration have issued the Notice on Administrative Measures for the Import Tax Incentive Policy for Science and Technology during the 15th Five-Year Plan (Caiguanshui [2026] No. 8). The administrative measures operate alongside the policy notice.

Local implementation: the Xiamen example

The Xiamen notice published on 10 October 2026 illustrates how the foreign-invested R&D centre route works in practice.

The approving authorities are the municipal commerce bureau together with the municipal finance bureau, customs and the municipal tax bureau. The approval conditions follow Annex 1 of Caiguanshui [2026] No. 8, “Conditions for Foreign-Invested R&D Centres Enjoying the Policy”.

Nine categories of application materials are required: the application form for foreign-invested R&D centres to enjoy the import tax incentive policy; an application letter covering basic information, R&D activities and a statement of conformity with the application conditions (where the centre is not an independent legal person, it must also cover the basic information of the foreign-invested enterprise it relies on); the business licence (a copy of the business licence for an independent legal person, or a copy of the business licence of the foreign-invested enterprise in which it is located for a non-independent legal person); information on total R&D investment (for an independent legal person, the foreign investment information report receipt showing the total investment amount; for a non-independent legal person, a list of total R&D investment assets, with a contract list for assets to be purchased where contracts are about to be signed); a roster of full-time research and experimental development personnel; a list of equipment cumulatively purchased since establishment (with a contract list for equipment under signed purchase contracts and due for delivery within the current year); a copy of the financial statements (or audit report) for the previous year; the most recent annual information report; and any other materials required by the approving authorities.

Applications are accepted twice a year. For the first half of the year, the window runs from 1 March to 15 March, with results released by 30 April. For the second half of the year, the window runs from 1 October to 25 October, with results released by 30 November. Additional application batches may be added where genuinely necessary.

Materials should be submitted in duplicate, in A4 format, bound in order, with the unit’s official seal on each item and a seal across the side edge.

Practical implications for foreign businesses

  • Confirm whether the centre qualifies as a foreign-invested R&D centre under Annex 1 of Caiguanshui [2026] No. 8. The policy route for a foreign-invested R&D centre is separate from the routes for domestic research institutes and universities, and the conditions in the annex are the test.
  • Plan around the second-half window of 1 October to 25 October. This is the most immediate timing point in the current batch: applications for the second half of the year close on 25 October, with results due by 30 November. Where the window has passed, the next regular opportunity is the March window, unless an additional batch is arranged.
  • Non-independent legal persons can apply. A foreign-invested R&D centre that is not an independent legal person submits the business licence of the foreign-invested enterprise it relies on and a list of total R&D investment assets. Centres that are organised as a department or branch rather than a separate company are therefore not excluded.
  • Treat the exemption as conditional on both the entity and the goods. The exemption applies to supplies that cannot be produced domestically or whose performance cannot meet requirements, and exempt goods are subject to list management with the list issued separately. The exemption should not be assumed to apply automatically to any import.
  • Assemble the nine categories of materials early. The materials span corporate documents, R&D personnel and equipment records, financial statements and information reports. Because each item must be sealed and the set bound in order, preparation time is a practical constraint.
  • Keep the approval linked to the tax and customs authorities. The approving body brings together commerce, finance, tax and customs. Aligning the application with all four reduces the risk of a gap between approval and the actual import exemption.

Related reading

  • Foreign R&D centres in China: support policies, imported research supplies and intellectual property positioning
  • The 15th Five-Year Plan and the wider incentive framework for foreign-invested R&D
  • Customs procedures for imported research and teaching supplies
  • Foreign investment information reporting for foreign-invested enterprises

Sources

  • 财政部安徽监管局·财关税〔2026〕7 号全文(含第三条 13 类主体、第四条清单管理):https://ah.mof.gov.cn/tongzhitonggao/202610/t20261012_4002591.htm
  • 厦门市商务局等四部门·外资研发中心核定条件、九类申报材料、下半年 10 月 1 日至 10 月 25 日申报窗口:https://swj.xm.gov.cn/zwgk/zfxxgk/ml/qtzfxx/202610/t20261010_3020527.htm
  • 财政部官网:https://www.mof.gov.cn/
  • 商务部官网:https://www.mofcom.gov.cn/

“十五五”期间支持科技创新进口税收优惠政策 2026:外资研发中心如何符合条件

概述

财政部等部门印发《关于”十五五”期间支持科技创新进口税收优惠政策的通知》(财关税〔2026〕7 号)。该通知于 2026 年 10 月 12 日经财政部安徽监管局等渠道公开。

通知对特定范围的科研、教育与出版机构给予进口税收优惠。第一条规定,对科学研究机构、技术开发机构、学校、党校(行政学院)、图书馆进口国内不能生产或性能不能满足需要的科学研究、科技开发和教学用品,免征进口关税和进口环节增值税、消费税。第二条规定,对出版物进口单位为上述机构进口用于科研、教学的图书、资料,免征进口环节增值税。

外资研发中心属于适用主体之一。本文梳理通知的适用范围、外资研发中心在其中的位置、清单管理要求,以及申报的实务步骤与时间安排。

2026 年主要进展

十三类适用主体

第三条规定了政策适用的主体范围:

  1. 从事科学研究工作的中央级、省级、地市级科研院所及其具有独立法人资格的研究生院、图书馆;
  2. 国家实验室、国家实验室基地;
  3. 全国重点实验室、国家新兴产业创新中心、国家制造业创新中心、国家技术创新中心、国家临床医学研究中心、国家产业技术工程化中心、国家大学科技园、”一带一路”联合实验室、国家重大科技基础设施、国家科技资源共享服务平台、国家野外科学观测研究站;
  4. 科技体制改革过程中转制为企业和进入企业的主要从事科学研究、技术开发工作的机构;
  5. 国家中小企业公共服务示范平台(技术类);
  6. 国家发展改革委企业技术中心;
  7. 省级商务主管部门会同省级财政、税务部门和所在地直属海关核定的外资研发中心;
  8. 科技部会同民政部核定的科技类民办非企业单位,省级科技主管部门会同省级民政、财政、税务部门和所在地直属海关核定的科技类民办非企业单位类新型研发机构;
  9. 省级科技主管部门会同省级财政、税务部门和所在地直属海关核定的事业单位类新型研发机构;
  10. 国家承认学历的实施专科及以上高等学历教育的高等学校及其具有独立法人资格的分校、异地办学机构;
  11. 县级及以上党校(行政学院);
  12. 地市级及以上公共图书馆;
  13. 中央宣传部核定的具有出版物进口许可的出版物进口单位。

清单管理:优惠并非自动享受

第四条规定,免税进口商品实行清单管理,免税进口商品清单由财政部会同有关部门另行制定印发。由此产生两点实务后果。其一,符合主体条件并不等于分析结束,具体商品还须落在清单范围内。其二,由于清单另行印发,免税的实际适用范围由该清单确定,而不仅由通知本身确定。

第一条还对商品本身设定了实质条件:免税适用于国内不能生产或性能不能满足需要的用品。这一条件与清单要求并列存在。

配套管理办法

财政部、中央宣传部、国家发展改革委、教育部、科技部、工业和信息化部、民政部、商务部、文化和旅游部、国家卫生健康委、海关总署、税务总局印发《关于”十五五”期间支持科技创新进口税收优惠政策管理办法的通知》(财关税〔2026〕8 号)。管理办法与政策通知配套执行。

地方落实:厦门范例

厦门市 2026 年 10 月 10 日发布的通知,展示了外资研发中心这一路径的实际操作方式。

核定部门为市商务局会同市财政局、海关、市税务局。核定条件按财关税〔2026〕8 号附件 1″享受政策的外资研发中心条件”执行。

申报材料共九类:外资研发中心享受进口税收优惠政策申报表;申请书(含基本情况、研发活动情况、符合申报条件的说明;属非独立法人的,还应包括所依托外商投资企业基本情况);营业执照(独立法人提交营业执照复印件,非独立法人提交其所在外商投资企业营业执照复印件);研发总投入情况(独立法人提供载有投资总额的外商投资信息报告回执;非独立法人提供研发总投入资产清单,即将投入并签订购置合同的资产应提交即将采购资产的合同清单);专职研究与试验发展人员名册;设立以来累计购置的设备清单(已签订购置合同并于当年内交货的设备应同时提交合同清单);上一年度财务报表(或审计报告)复印件;最近一期的年度信息报告书;审核部门要求的其他材料。

申报每年开展两次。上半年为 3 月 1 日至 3 月 15 日,核定结果于 4 月 30 日前发布;下半年为 10 月 1 日至 10 月 25 日,核定结果于 11 月 30 日前发布。如确有必要,可增加申报批次。

材料要求为一式二份,A4 规格,按顺序装订成册,每项材料加盖单位公章,并在侧面骑缝加盖公章。

对外资企业的实务意义

  • 先确认研发中心是否符合财关税〔2026〕8 号附件 1 的条件。 外资研发中心的政策路径与国内科研院所、高校的路径相互独立,附件所列条件即为判定标准。
  • 围绕 10 月 1 日至 10 月 25 日的下半年窗口安排时间。 这是本批次最直接的时间节点:下半年申报于 10 月 25 日截止,核定结果于 11 月 30 日前发布。若窗口已过,下一次常规机会为次年 3 月窗口,除非另行增加批次。
  • 非独立法人也可申报。 非独立法人的外资研发中心提交其所依托外商投资企业的营业执照以及研发总投入资产清单。以部门或分支机构形式而非独立公司形式设立的中心,并不因此被排除在外。
  • 把优惠理解为”主体 + 商品”双重条件。 免税适用于国内不能生产或性能不能满足需要的用品,且免税商品实行清单管理、清单另行印发。不应假定任何进口都自动适用免税。
  • 尽早准备九类材料。 材料涉及企业证照、研发人员与设备记录、财务报表与信息报告等。由于每项材料均须盖章并按顺序装订,准备周期是一项现实约束。
  • 让核定与税务、海关环节保持衔接。 核定部门由商务、财政、税务与海关共同组成。在申报阶段同步对接四方,可降低核定通过后与实际进口免税之间的落差风险。

相关阅读

  • 外资研发中心在华:支持政策、进口科研用品与知识产权布局
  • “十五五”规划与外资研发中心更广泛的优惠框架
  • 进口科研与教学用品的海关流程
  • 外商投资企业的外商投资信息报告

来源

  • 财政部安徽监管局·财关税〔2026〕7 号全文(含第三条 13 类主体、第四条清单管理):https://ah.mof.gov.cn/tongzhitonggao/202610/t20261012_4002591.htm
  • 厦门市商务局等四部门·外资研发中心核定条件、九类申报材料、下半年 10 月 1 日至 10 月 25 日申报窗口:https://swj.xm.gov.cn/zwgk/zfxxgk/ml/qtzfxx/202610/t20261010_3020527.htm
  • 财政部官网:https://www.mof.gov.cn/
  • 商务部官网:https://www.mofcom.gov.cn/

CNIPA and GACC Joint Opinion 2026: Strengthened IPR Customs Protection for Trademark and Patent Owners

  • On 8 October 2026 the China National Intellectual Property Administration and the General Administration of Customs jointly issued the Opinions on Strengthening Coordinated Intellectual Property Protection, released publicly on 14 October.
    2026 年 10 月 8 日,国家知识产权局与海关总署联合印发《关于强化知识产权协同保护的意见》,并于 10 月 14 日公开发布。
  • The Opinions set out seven areas of work, covering information sharing, investigation assistance, business support, key-sector protection, joint research, talent development and evaluation.
    《意见》提出七项重点工作,涵盖信息共享、调查协助、业务支撑、重点领域保护、会商调研、人才培养和评估奖惩。
  • Under information sharing, CNIPA will provide customs with trademark and patent basic data on a regular basis to make it easier for rights holders to complete customs recordation.
    在信息共享方面,国家知识产权局将定期向海关总署提供商标、专利等基础数据信息,便利权利人办理海关备案。
  • The two authorities will also share well-known trademark confirmations, records of revoked or invalidated trademarks, and decisions in major patent infringement administrative rulings.
    双方还将共享驰名商标确认信息、撤销或者宣告无效的商标信息,以及重大专利侵权纠纷行政裁决决定信息。
  • For patent cases involving technical questions, CNIPA will recommend experts such as technical investigation officers to customs according to customs needs.
    对涉及专业技术性事项的专利侵权案件,国家知识产权局将根据海关需求推荐技术调查官等专家。
  • The Opinions encourage rights holders with well-known trademark records, collective or certification marks registered as geographical indications, and photovoltaic and other key industry enterprises to file customs recordation.
    《意见》鼓励有驰名商标确认记录、作为地理标志注册的集体商标或证明商标,以及光伏等重点产业企业的权利人积极向海关申请知识产权备案。
  • The customs recordation system itself already exists; the Opinions strengthen coordination around it rather than creating a new recordation regime.
    海关知识产权备案制度本身早已存在;《意见》是在其基础上强化协同,而非新设一项备案制度。
  • Implementation is led by the IP Protection Department of CNIPA and the Comprehensive Business Department of GACC, which will establish a standing liaison mechanism with designated contacts.
    落实工作由国家知识产权局知识产权保护司与海关总署综合业务司牵头,建立常态化联络机制并确定联络人。

CNIPA and GACC Joint Opinion 2026: Strengthened IPR Customs Protection for Trademark and Patent Owners | 国家知识产权局与海关总署 2026 年联合意见:商标与专利权利人的知识产权海关保护协同

Overview

On 8 October 2026, the China National Intellectual Property Administration (CNIPA) and the General Administration of Customs (GACC) jointly issued the Opinions on Strengthening Coordinated Intellectual Property Protection (《关于强化知识产权协同保护的意见》). The document was released publicly on 14 October 2026.

The stated aim is to combine the strengths of the intellectual property administration and customs so that the two work as one force, advance protection across the whole intellectual property chain, and support a sound business and innovation environment. For trademark and patent owners, the practical question is what the coordination changes at the border and in the recordation process, and what it does not change. This article sets out the seven areas of work, reproduces the official wording where it matters, and identifies the practical handles for foreign rights holders. It does not extend the text beyond what the document says.

Key developments in 2026

The Opinions are organised into seven areas of work, together with implementation arrangements.

Information sharing. The two authorities will establish a long-term working mechanism for data sharing and application. CNIPA will provide GACC with trademark and patent basic data on a regular basis, which makes it easier for rights holders to complete customs recordation. The two will also share well-known trademark confirmation information, information on trademarks that have been revoked or declared invalid, and decisions in major patent infringement administrative dispute rulings, to assist customs enforcement. GACC will provide CNIPA with data on trademarks and patents that have been recorded for customs protection and on trademark and patent cases in which goods have been confiscated. The two will notify each other of their administrative enforcement replies in trademark and patent matters, to promote consistency in infringement assessment standards, and will jointly advance intellectual property informatisation.

Investigation assistance. Where the intellectual property administration handles a trademark or patent infringement case involving imported or exported goods and requests customs assistance, customs is to provide it. Where customs investigates suspected infringing goods that have been detained and requests assistance, the intellectual property administration is to assist. For patent infringement cases involving specialised technical matters, CNIPA will recommend experts such as technical investigation officers according to customs needs. Verification of registered trademark information and status may be carried out through the CNIPA trademark registration certificate public notice system.

Business support. When customs investigates goods suspected of infringing trademark or patent rights, it will refer fully to the infringement assessment standards formulated by CNIPA as well as to relevant administrative replies and administrative ruling decisions made by the intellectual property administration. For relatively specialised and complex questions of identification — the same goods, similar goods, identical trademarks, similar trademarks and patent infringement — customs may seek the views of the intellectual property administration at the same level, which is to reply in a timely manner and issue a professional opinion.

Key-sector protection. The intellectual property administration encourages rights holders with well-known trademark confirmation records, collective or certification marks registered as geographical indications, and photovoltaic and other key industry enterprises to actively apply to customs for intellectual property recordation. GACC reviews applications in accordance with the law, and once recordation is completed, customs strengthens protection based on national industrial policy and the results of risk analysis.

Joint research, talent and evaluation. The two will hold discussions on difficult trademark and patent cases, conduct joint research on major difficult issues to promote consistency in enforcement standards, and jointly advance the use of new technologies such as artificial intelligence and big data in intellectual property protection. They will exchange teaching resources and support specialised training on foreign-related intellectual property protection. They will periodically evaluate the effectiveness of protection work, publicly commend outstanding collectives and individuals, and remind those whose work is lagging.

Implementation. The work is led by the IP Protection Department of CNIPA and the Comprehensive Business Department of GACC, which will establish a standing liaison mechanism and designate contacts. Intellectual property administration departments below the provincial level and customs offices directly under GACC will establish corresponding liaison mechanisms.

Practical implications for foreign businesses

Five practical handles follow for foreign trademark and patent owners.

First, recordation remains the core instrument. Customs active protection applies to trademarks and patents that have been recorded; the Opinions reinforce the recordation process rather than replace it. The information-sharing measures are designed to make recordation easier to complete.

Second, certain categories of rights holders are explicitly encouraged to apply for recordation: those with well-known trademark confirmation records, collective or certification marks registered as geographical indications, and photovoltaic and other key industry enterprises. Once recorded, customs strengthens protection based on national industrial policy and risk analysis.

Third, technical investigation officers now enter the customs case-support system. For patent matters, where the technical questions are specialised, CNIPA may recommend experts such as technical investigation officers according to customs needs, so patent infringement assessment does not rest on customs judgement alone.

Fourth, consistency of infringement assessment standards improves predictability. Customs refers to CNIPA’s infringement assessment standards and to administrative replies and rulings, and may consult the intellectual property administration at the same level on difficult identification questions.

Fifth, specialised training on foreign-related intellectual property protection is written into the document, indicating a direction of professionalisation in cross-border enforcement.

One clarification belongs in any complete reading. The Opinions do not create a new recordation regime. Customs intellectual property recordation has long existed under the applicable customs rules. What the Opinions do is strengthen coordination around that existing framework — through data sharing, investigation assistance, standard alignment and key-sector encouragement — so that the two authorities act with a common understanding. Rights holders who already hold recordation, and those considering it, should read the document as an improvement in the operating environment for enforcement at the border.

Related reading

  • Customs intellectual property recordation is the gateway to customs active protection for recorded trademarks and patents.
  • For patent cases involving specialised technical matters, CNIPA may recommend experts such as technical investigation officers to customs.
  • Rights holders with well-known trademark records, geographical indication collective or certification marks, and photovoltaic and other key industry enterprises are encouraged to apply for recordation.

Sources

  • 国家知识产权局官网·《关于强化知识产权协同保护的意见》全文:https://www.cnipa.gov.cn/art/2026/10/14/art_3611_208509.html?xxgkhide=1
  • 中国金融新闻网·两部门联合印发及七项重点工作全文(2026-10-14):https://www.financialnews.com.cn/2026-10/14/content_458807.html
  • 新华报业网转央视·重点领域保护报道:https://www.xhby.net/content/s6acf29f1e4b0cd8a37594433.html
  • 海关总署官网(海关知识产权保护相关公告与政策栏目):http://www.customs.gov.cn/

国家知识产权局与海关总署 2026 年联合意见:商标与专利权利人的知识产权海关保护协同

概述

2026 年 10 月 8 日,国家知识产权局与海关总署联合印发《关于强化知识产权协同保护的意见》,并于 2026 年 10 月 14 日公开发布。

《意见》的目标是发挥知识产权管理部门与海关的各自优势,形成工作合力,协同推进知识产权全链条保护,营造良好营商环境和创新环境。对商标与专利权利人而言,实务问题在于:这一协同在口岸环节与备案流程中改变了什么,又没有改变什么。本文梳理《意见》的七项重点工作,在关键处照录官方原文表述,并指出外资权利人的实操抓手。本文不超出文件本身所写的内容作延伸。

2026 年的关键进展

《意见》分为七项重点工作,并配有落实安排。

加强信息共享。 双方将建立数据共享应用合作长效工作机制。国家知识产权局定期向海关总署提供商标、专利等基础数据信息,便利权利人办理海关备案;同时共享驰名商标确认信息、撤销或者宣告无效的商标信息,以及重大专利侵权纠纷行政裁决决定信息,辅助海关执法。海关总署定期向国家知识产权局提供进行海关保护备案的商标、专利数据信息,以及予以没收的商标、专利案件信息。双方互相通报各自作出的商标、专利行政执法答复,促进商标、专利侵权判断标准统一,并共同推动知识产权信息化建设。

强化调查协助。 知识产权管理部门处理涉及进出口货物的商标、专利侵权案件请求海关协助的,海关应当予以协助;海关对被扣留的侵权嫌疑货物进行调查请求协助的,知识产权管理部门应当协助。对涉及专业技术性事项的专利侵权案件,国家知识产权局将根据海关需求推荐技术调查官等专家。核实注册商标信息及状态,可通过国家知识产权局商标注册证明公示系统进行。

加强业务支撑。 海关调查涉嫌侵犯商标权、专利权的货物时,充分参考国家知识产权局制定的侵权判断标准,以及知识产权管理部门作出的相关行政答复、行政裁决决定;遇较专业复杂的同一种商品、类似商品、相同商标、近似商标、专利侵权等认定问题,可征求同级知识产权管理部门意见,知识产权管理部门应及时答复、出具专业意见。

强化重点领域保护。 知识产权管理部门鼓励有驰名商标确认记录、作为地理标志注册的集体商标或证明商标,以及光伏等重点产业企业的权利人,积极向海关申请知识产权备案。海关总署依法审核;经海关总署备案后,海关基于国家产业政策和风险分析结果加强保护。

加强会商调研、人才培养和评估奖惩。 双方就商标、专利疑难案件开展研讨,对重大疑难问题联合调研,促进执法标准统一;共同推进人工智能、大数据等新技术在知识产权保护工作中的应用。互派师资,支持涉外知识产权保护专业培训。定期评估保护工作成效,对突出集体和个人通报表扬,对工作不力的督促提醒。

落实安排。 工作由国家知识产权局知识产权保护司与海关总署综合业务司牵头,建立常态化联络机制、确定联络人;省级以下知识产权管理部门、直属海关建立相应联络机制。

对外资企业的实务意义

对外资商标与专利权利人而言,有五个实操抓手。

第一,备案仍是核心抓手。海关的主动保护适用于已备案的商标与专利;《意见》强化的是围绕备案流程的协同,而非取而代之。信息共享方面的举措,目的在于让备案更便于完成。

第二,若干类权利人被明确鼓励申请备案:有驰名商标确认记录的、作为地理标志注册的集体商标或证明商标的,以及光伏等重点产业企业的权利人。备案完成后,海关基于国家产业政策和风险分析结果加强保护。

第三,技术调查官进入海关办案支持体系。就专利事项而言,遇专业技术性较强的问题,国家知识产权局可根据海关需求推荐技术调查官等专家,专利侵权认定不再只依赖海关自身判断。

第四,侵权判断标准趋于统一,可预期性提升。海关参考国家知识产权局的侵权判断标准及相关行政答复、裁决,遇疑难认定问题还可征求同级知识产权管理部门意见。

第五,涉外知识产权保护专业培训被写入文件,指向跨境维权的专业化方向。

任何完整的解读都应包含一处澄清。《意见》并未新设一项备案制度。海关知识产权备案制度早已存在,其依据是适用的海关规则。《意见》所做的是围绕这一既有框架强化协同——通过数据共享、调查协助、标准衔接与重点领域鼓励,使两个部门以一致理解开展工作。已持有备案的权利人,以及正在考虑备案的权利人,宜将该文件理解为口岸执法营商环境的改善。

延伸阅读

  • 海关知识产权备案,是已备案商标与专利获得海关主动保护的前提。
  • 对涉及专业技术性事项的专利侵权案件,国家知识产权局可根据海关需求推荐技术调查官等专家。
  • 有驰名商标确认记录、作为地理标志注册的集体商标或证明商标,以及光伏等重点产业企业的权利人,被鼓励申请备案。

来源

  • 国家知识产权局官网·《关于强化知识产权协同保护的意见》全文:https://www.cnipa.gov.cn/art/2026/10/14/art_3611_208509.html?xxgkhide=1
  • 中国金融新闻网·两部门联合印发及七项重点工作全文(2026-10-14):https://www.financialnews.com.cn/2026-10/14/content_458807.html
  • 新华报业网转央视·重点领域保护报道:https://www.xhby.net/content/s6acf29f1e4b0cd8a37594433.html
  • 海关总署官网(海关知识产权保护相关公告与政策栏目):http://www.customs.gov.cn/

Brain-computer interface medical devices: China’s innovative registration policy direction

  • At the 2026 International Biomedical Industry Innovation Beijing Forum in Yizhuang, an official from the NMPA Medical Device Registration Management Department said brain-computer interface (BCI) has been incorporated into China’s 15th Five-Year Plan and written into the Government Work Report, and is positioned as a future industry.
    在2026国际生物医药产业创新北京论坛(北京亦庄)”神经调控与脑机接口技术产业发展论坛”上,国家药监局医疗器械注册管理司相关负责人表示,脑机接口已被纳入我国”十五五”规划、写入政府工作报告,明确作为未来产业予以布局。
  • The regulator signalled that supporting innovative registration and management policies will be introduced to systematically support the development and translation of BCI medical devices.
    药监部门表示将配套创新注册管理政策,系统支持脑机接口医疗器械的研发与落地转化。
  • As of end-July 2026, China had more than 347,000 valid medical-device registrations and filings; in 2025 the NMPA approved 14,187 medical-device registrations, up 8 per cent year on year.
    截至2026年7月底,全国有效医疗器械注册备案产品超过34.7万件;2025年国家药监局共批准医疗器械注册14187项,同比增长8%。
  • The “Spring Rain Action” clinical-translation programme has collected more than 400 Class III medical-device products and placed 22 quality projects into an expedited pre-review green channel.
    医疗器械临床创新成果转化”春雨行动”已征集400多个三类医疗器械产品,已有22个优质项目纳入审评前置绿色通道。
  • On standards, three industry standards for BCI have been issued, ten national standards and three industry standards are under development, and one international-standard proposal has been submitted, covering EEG acquisition, signal transmission, motor-intention decoding and device reliability.
    在标准方面,脑机接口领域已累计发布3项行业标准,立项10项国家标准、3项行业标准,并提交1项国际标准立项提案,覆盖脑电采集、信号传输、运动意图解码与设备可靠性等核心技术环节。
  • The regulator describes its approach as “front-loading regulation and standards first”, including pre-application technical guidance for both invasive and non-invasive products and unified naming and classification rules.
    监管方式被概括为”监管前置、标准先行”,包括对多款侵入式、非侵入式产品开展前置技术指导,并统一产品命名与分类界定规则。
  • For foreign companies the practical relevance is analytical rather than a formal commitment: the policy direction points to clearer registration pathways, but no specific BCI approval timelines, acceptance numbers or product names have been published.
    对境外企业而言,其实际意义属分析性判断而非官方承诺:政策方向指向更清晰的注册路径,但截至目前并未公布具体的脑机接口审批时限、受理编号或产品名称。

Brain-computer interface medical devices: China’s innovative registration policy direction | 脑机接口医疗器械:中国创新注册管理政策方向

Overview

In October 2026, the 2026 International Biomedical Industry Innovation Beijing Forum was held in Yizhuang, Beijing. At the forum’s “Neuromodulation and Brain-Computer Interface Technology Industry Development Forum”, an official from the Medical Device Registration Management Department of the National Medical Products Administration (NMPA) set out the regulator’s current reading of brain-computer interface (BCI) medical devices and the registration policy direction attached to them.

According to the remarks, BCI has been incorporated into China’s 15th Five-Year Plan and written into the Government Work Report, and is expressly positioned as a future industry. On that basis, the regulator said it would put in place supporting innovative registration and management policies to systematically support the research, development and translation of BCI medical devices.

The remarks are a policy-direction statement rather than a new rule. They describe how the existing medical-device registration system is being oriented towards BCI, and they rest on a set of published industry figures that show how the registration base and the innovation-support toolkit have grown.

Key developments

The official’s remarks combined a positioning statement with concrete numbers on China’s medical-device registration landscape.

  • Registration base. As of end-July 2026, China had more than 347,000 valid medical-device registrations and filings, spanning Class III registration certificates, Class II registration certificates and Class I filings.
  • Annual approvals. In 2025, the NMPA approved 14,187 medical-device registrations, an increase of 8 per cent year on year.
  • Clinical translation programme. The “Spring Rain Action” for the translation of clinical innovations in medical devices had collected more than 400 Class III medical-device products, covering high-end tracks such as BCI, interventional surgical robots, AI diagnostic software and high-end interventional implants and biomaterials. 22 quality projects had been placed into an expedited pre-review green channel.

Read together, these figures describe a large and still-growing registration pipeline, and a deliberate effort to move selected high-end products through review faster than the ordinary queue.

Standards first: the pre-review and standards toolkit

Alongside the registration figures, the remarks described the regulator’s operating approach as “front-loading regulation and standards first”.

On standards, the BCI field has seen:

  • three industry standards issued;
  • ten national standards and three industry standards initiated (立项); and
  • one international-standard proposal submitted.

The published standards cover core technical links including EEG acquisition, signal transmission, motor-intention decoding and device reliability.

On regulation, the approach includes:

  • advance planning of regulatory-science research;
  • pre-application technical guidance for a number of both invasive and non-invasive products; and
  • unified rules for product naming and classification.

The “standards first” logic matters for a technology like BCI, where the boundary between a medical device, a consumer wearable and a research instrument can be genuinely unclear. Naming and classification rules, and the existence of standards for core components, are the practical preconditions for a device to move into a defined registration pathway.

Next steps in regulation

The official set out the next steps in general terms: continuing to deepen reform of the medical-device review and approval system and to increase support for high-end innovative devices. Specific measures mentioned included:

  • optimising the review mechanism for “globally new” products;
  • providing front-loaded services such as clinical-trial pre-review and technical consultation; and
  • thereby accelerating the market launch of landmark products.

These are direction statements. They indicate where the regulator intends to concentrate facilitation effort, not the terms on which any individual product will be reviewed.

Practical implications for foreign companies

The following points are analytical observations, not official commitments. They describe what the policy direction may mean for foreign BCI and neurotechnology companies considering the China market.

  • The direction of travel is clearer, the details are not. A stated intent to build supporting innovative registration policies for BCI signals that the regulator is treating the field as a priority. It does not, on its own, change any filing requirement, and no BCI-specific approval timeline, acceptance number or product name has been published.
  • Classification and naming are the first practical questions. Because the regulator is unifying naming and classification rules for BCI, a company’s early task is to understand how its product would be classified and named under the Chinese system, since that determines the registration pathway.
  • Standards participation is a defined channel. With national and industry standards under development and an international-standard proposal submitted, there is an active standards-setting process. Foreign companies commonly monitor or participate in such processes through their China entities or industry associations, though the terms of participation follow the applicable standards rules.
  • Patent and intellectual-property positioning deserves early attention. BCI spans hardware, signal-processing algorithms and software. Companies usually review how their patent portfolio maps onto the Chinese classification and standards landscape before committing to a registration strategy. This is a commercial and legal planning point, not a statement of any regulatory preference.
  • Translation programmes are a signal, not a guarantee. The “Spring Rain Action” pipeline shows that a subset of high-end products is being routed into an expedited pre-review channel. Being in a high-priority field is relevant context, but selection for such programmes is a separate process.

Related considerations

For a foreign company, the sensible reading of these remarks is as a map of the regulator’s priorities rather than a set of entitlements. The registration figures show scale; the standards activity shows the field maturing towards defined technical requirements; and the “front-loading” language shows where facilitation effort is being directed. A company planning a China BCI strategy would typically combine this policy context with a product-specific review of classification, standards alignment, patent position and the appropriate registration pathway, and would confirm current requirements against the latest official publications before relying on any particular route.

Sources

  • 经济参考报 2026-10-08 报道(环球医药网转载)— 脑机接口纳入”十五五”规划与创新注册管理政策表态: https://www.qgyyzs.net/news/newshtml/hyxx/20261008090946.shtml
  • 中国政府网 — 未来产业与”十五五”规划政策背景: https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网(受权发布)— 《关于发展新质生产力的意见》全文(含”前瞻布局未来产业”等产业定位表述): https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml

脑机接口医疗器械:中国创新注册管理政策方向

概述

2026年10月,2026国际生物医药产业创新北京论坛在北京亦庄举行。在该论坛的”神经调控与脑机接口技术产业发展论坛”上,国家药品监督管理局医疗器械注册管理司相关负责人就脑机接口医疗器械的监管现状与注册政策方向作了介绍。

据该负责人介绍,脑机接口已被纳入我国“十五五”规划、写入政府工作报告,明确作为未来产业予以布局。在此基础上,药监部门表示将配套创新注册管理政策,系统支持脑机接口医疗器械的研发与落地转化。

上述表态属政策方向性说明,而非新出台的规则。它描述的是现行医疗器械注册体系正如何向脑机接口领域倾斜,并以一组已公布的行业数据为依托,展示注册基数与创新支持工具的发展情况。

主要进展

该负责人的介绍将产业定位与具体数据结合在一起,勾勒出我国医疗器械注册的整体面貌。

  • 注册基数。 截至2026年7月底,全国有效医疗器械注册备案产品超过34.7万件,涵盖三类注册证、二类注册证及一类备案产品。
  • 年度批准量。 2025年,国家药监局共批准医疗器械注册14187项,同比增长8%。
  • 临床转化项目。 医疗器械临床创新成果转化“春雨行动”已征集400多个三类医疗器械产品,覆盖脑机接口、介入手术机器人、人工智能诊疗软件、高端植介入生物材料等高端赛道;已有22个优质项目纳入审评前置绿色通道。

综合来看,这组数据一方面说明注册管线规模庞大且仍在增长,另一方面也说明监管机构有意让部分高端产品以快于常规队列的方式通过审评。

标准先行:前置审评与标准工具箱

在注册数据之外,该负责人将监管机构的运行思路概括为“监管前置、标准先行”。

在标准方面,脑机接口领域已实现:

  • 累计发布3项行业标准;
  • 立项10项国家标准、3项行业标准;
  • 提交1项国际标准立项提案。

已发布的标准覆盖脑电采集、信号传输、运动意图解码、设备可靠性等核心技术环节。

在监管方面,相关做法包括:

  • 提前布局监管科学研究;
  • 对多款侵入式、非侵入式产品开展前置技术指导;
  • 统一产品命名与分类界定规则。

“标准先行”的逻辑对脑机接口这类技术尤为重要——医疗器械、消费级可穿戴设备与研究仪器之间的边界有时并不清晰。命名与分类界定规则,以及核心部件标准的建立,是产品得以进入明确注册路径的现实前提。

下一步监管方向

该负责人以总体表述方式提出了下一步方向:持续深化医疗器械审评审批制度改革,持续加大高端创新器械扶持力度。其中提到的具体举措包括:

  • 优化”全球新”产品审评机制;
  • 提供临床试验预审、技术咨询等前置服务;
  • 进而加速标杆产品上市。

这些属方向性表述,指示监管机构拟在何处集中便利化资源,并不等同于任何单一产品的审评条件。

对境外企业的实务意义

以下要点为分析性观察,并非官方承诺。它们描述的是该政策方向对考虑进入中国市场的境外脑机接口与神经技术企业可能意味着什么。

  • 方向更清晰,细节尚未明确。 表态提出将为脑机接口构建配套创新注册政策,说明监管机构将该领域视为优先方向。但这一表态本身并不改变任何申报要求,且截至目前并未公布脑机接口专属的审批时限、受理编号或产品名称。
  • 分类与命名是首要实务问题。 由于监管机构正在统一脑机接口的命名与分类界定规则,企业的早期工作之一是弄清其产品在中国体系下将被如何分类与命名,因为这决定了注册路径。
  • 参与标准化是一条既有通道。 随着国家标准与行业标准在研、国际标准提案已提交,标准化进程处于活跃状态。境外企业通常通过其在华主体或行业协会关注或参与此类进程,但参与条件须遵循适用的标准化管理规定。
  • 专利与知识产权布局宜及早关注。 脑机接口横跨硬件、信号处理算法与软件。企业通常会在确定注册策略前,先梳理其专利组合如何对应中国的分类与标准格局。这属商业与法律规划事项,并非监管倾向性表述。
  • 转化项目是信号,而非保证。 “春雨行动”管线显示,部分高端产品正被纳入审评前置快速通道。身处高优先级领域是相关背景,但能否入选此类项目是另一套独立程序。

相关考量

对境外企业而言,将上述表态理解为监管机构优先事项的路线图,比理解为一系列既得权益更为妥当。注册数据体现规模,标准化活动体现该领域正走向明确的技术要求,”前置”表述则体现便利化资源投入的方向。规划中国脑机接口战略的企业,通常会将这一政策背景与针对具体产品的分类、标准对齐、专利布局及相应注册路径评估结合起来,并在依赖任何具体路径前,依据最新官方发布确认现行要求。

来源

  • 经济参考报 2026-10-08 报道(环球医药网转载)— 脑机接口纳入”十五五”规划与创新注册管理政策表态: https://www.qgyyzs.net/news/newshtml/hyxx/20261008090946.shtml
  • 中国政府网 — 未来产业与”十五五”规划政策背景: https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网(受权发布)— 《关于发展新质生产力的意见》全文(含”前瞻布局未来产业”等产业定位表述): https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml

Traditional Chinese Medicine Knowledge Protection: What the September 2026 Draft Regulation Means for Foreign Pharmaceutical and Healthcare Companies

  • On 18 September 2026, the State Council executive meeting reviewed and approved in principle the Draft Regulation on the Protection of Traditional Chinese Medicine Knowledge, describing traditional Chinese medicine theory, techniques and formulas as important resources for China’s own innovation and calling for comprehensive strengthening of protection and management.
    2026年9月18日,国务院常务会议审议通过《中医药传统知识保护条例(草案)》,会议指出中医药理论、技术和方药是我国自主创新的重要资源,要全面加强保护管理。
  • The regulation is to establish a protection system for traditional Chinese medicine knowledge: after registration and review-based recognition, a holder enjoys rights to indicate identity, to transmit and use, to informed consent, to benefit sharing, to integrity protection and to require disclosure of source, while medical institutions are encouraged to proactively investigate and develop proven formulas, secret formulas and techniques.
    条例将建立中医药传统知识保护制度:经登记并审核认定后,持有人享有表明身份、传承使用、知情同意、利益分享、完整保护、要求说明来源等权利,并鼓励医疗机构主动调查发现中医药验方、秘方和技法并进行开发研究。
  • The draft has not been published in full, so no article numbers, effective date, registration procedure or recognition thresholds are available; planning should rest on the official record as it appears.
    草案尚未公布全文,条款编号、生效日期、登记程序与认定门槛均无从确认;相关规划应以官方后续发布为准。
  • The IP Protection and Application 15th Five-Year Plan (State Council document No. 30 of 2026, issued on 27 July 2026) already lists “issuing the Regulation on the Protection of Traditional Chinese Medicine Knowledge” and strengthening access and benefit-sharing systems for traditional knowledge and folk literature and art.
    《知识产权保护和运用”十五五”规划》(国发〔2026〕30号,国务院2026年7月27日印发)已明确”出台中医药传统知识保护条例”,并加强传统知识、民间文艺等获取和惠益分享制度建设。
  • The same Plan directs improvement of intellectual property protection rules for algorithms and AI-generated output and exploration of data intellectual property protection rules, matters relevant to digital health and AI-assisted research.
    同一规划还提出完善算法、人工智能生成物等知识产权保护规则,探索构建数据知识产权保护规则,与数字健康及人工智能辅助研究密切相关。
  • The revised Trademark Law was adopted on 26 June 2026 and takes effect on 1 January 2027; it writes the principle of good faith into the law and targets bad-faith filings, trademark hoarding and agency conduct.
    新修订《商标法》于2026年6月26日通过、2027年1月1日施行,将诚实信用原则写入法律,并针对恶意抢注、商标囤积及代理行为作出规范。

Traditional Chinese Medicine Knowledge Protection: What the September 2026 Draft Regulation Means for Foreign Pharmaceutical and Healthcare Companies | 中医药传统知识保护:2026年9月国务院常务会议审议通过条例草案对外资医药与大健康企业的意义

Overview

On 18 September 2026, the State Council executive meeting reviewed and approved in principle the Draft Regulation on the Protection of Traditional Chinese Medicine Knowledge. In the official account, traditional Chinese medicine theory, techniques and formulas are described as important resources for China’s own innovation, and the requirement is to comprehensively strengthen their protection and management. The draft has not yet been published in full.

For foreign pharmaceutical, healthcare and wellness companies working in or with China, the development matters for a practical reason. It sits alongside a wider set of intellectual property measures that took effect or moved through the system in 2026, from the revised Trademark Law to the IP Protection and Application 15th Five-Year Plan. Together they shape how traditional knowledge, research collaboration and brand assets are documented and defended.

This article sets out the official wording, the protection system as described, the institutional arrangements in the 15th Five-Year Plan, and the practical points foreign companies may wish to consider. It deliberately does not speculate beyond the official record.

The September 2026 decision

The executive meeting approved the draft and set the direction of policy. Traditional Chinese medicine theory, techniques and formulas are treated as important resources for China’s own innovation, and the task set is to comprehensively strengthen protection and management.

The regulation is to establish a protection system for traditional Chinese medicine knowledge. Under that system, after registration and review-based recognition, a holder enjoys a set of rights: to indicate identity, to transmit and use the knowledge, to give informed consent, to share in benefits, to integrity protection, and to require disclosure of source.

The official account also encourages medical institutions to proactively investigate and discover traditional Chinese medicine proven formulas, secret formulas and techniques, and to carry out development and research on them.

Because the full text has not been published, no article numbers, effective date, registration procedure or definitional thresholds are available. Companies should treat any such details as pending until an official release appears, and should not rely on descriptions that circulate without an official source.

What the 15th Five-Year Plan already provides

The draft regulation is not an isolated initiative. The IP Protection and Application 15th Five-Year Plan (State Council document No. 30 of 2026, issued on 27 July 2026) had already placed it within a wider programme.

The Plan calls for accelerating improvement of the patent-related legal system, for comprehensively revising the Trademark Law and its implementing regulations, and for issuing the Regulation on the Protection of Traditional Chinese Medicine Knowledge. It also directs strengthening access and benefit-sharing systems for traditional knowledge, folk literature and art, and improving intellectual property protection rules for algorithms and AI-generated output as well as for platform-economy development. It further calls for exploring data intellectual property protection rules.

The Plan sets out milestones. By 2030, China’s comprehensive intellectual property strength and international competitiveness are to be further enhanced, with decisive progress in building an intellectual property power. Looking to 2035, comprehensive intellectual property competitiveness is to rank among the world’s leading.

For a company mapping its China research and brand strategy, the Plan is useful because it shows the direction of travel across several instruments at once rather than the detail of a single new rule.

Adjacent intellectual property developments in 2026

A nationwide briefing tour on new intellectual property rules began in Jinan on 20 September 2026, covering the Shandong and Anhui region. The briefings addressed three instruments.

The revised Trademark Law writes the principle of good faith into the law, targets bad-faith filings and the hoarding of trademarks, tightens supervision of trademark agencies and strengthens industry credit constraints. It was adopted on 26 June 2026 and takes effect on 1 January 2027.

The revised Regulation on the Protection of Layout Designs of Integrated Circuits brings layout designs performing functions such as integrated photonics and quantum into the statutory scope of protection and establishes an originality declaration system.

The revised Measures for the Prioritised Examination of Patents steer prioritised examination resources toward emerging industries and key core technology programmes, and establish a central-local coordination mechanism.

Read together with the traditional knowledge regulation, these measures point in a consistent direction: more explicit documentation of what is claimed, who holds it and where it came from.

Practical implications for foreign pharmaceutical and healthcare companies

Due diligence on traditional knowledge. Where a project touches formulas, techniques or sources of traditional knowledge, the rights described in the official account — identity, transmission and use, informed consent, benefit sharing, integrity protection and disclosure of source — suggest that provenance and consent questions may become part of the record. Companies may wish to document how a formula or technique was obtained and on what terms.

Collaboration agreements. Research with hospitals, institutes and practitioners should be documented, with clarity on background and foreground rights, on publication, and on how jointly created results are handled.

Patent and brand layout. The Plan’s direction on patents and the revised Trademark Law both reward early, well-documented filing strategies. A portfolio that depends on distinctive names and marks should be checked against the good-faith and bad-faith filing provisions as they take effect.

Digital and AI-related work. The Plan’s references to algorithms, AI-generated output and data intellectual property are relevant to digital health, AI-assisted screening and data-driven research, where ownership of outputs and datasets is often unsettled.

Watch the official record. Because the draft regulation is not yet published in full, the specific registration route, recognition criteria and benefit-sharing mechanics remain to be seen. Planning should be revisited when the text and any supporting measures are released.

Related considerations

Foreign-invested companies in the healthcare and wellness sectors already work within sector-specific rules on drugs, devices, healthcare services and advertising. The traditional knowledge regulation adds a knowledge-protection layer rather than replacing those rules. Keeping the two layers distinct — what may be made and sold, and what knowledge may be used and on what terms — helps avoid conflating a licensing question with a market-access question.

Sources

  • 国家知识产权局(《知识产权保护和运用”十五五”规划》专栏): https://www.cnipa.gov.cn/col/col3692/index.html
  • 酒泉市公安局(《知识产权保护和运用”十五五”规划》国发〔2026〕30号全文转载): https://gaj.jiuquan.gov.cn/gaj/c106483/202609/856895252998428d9990e67d9af39108.shtml
  • 国家知识产权局(官网,9月工作动态): https://www.cnipa.gov.cn/?filter=0
  • 大众网滨州(知识产权新规全国巡回宣贯,9月20日济南,9-23): https://www.toutiao.com/article/7688564714451780098/
  • 中国政府网: https://www.gov.cn/

中医药传统知识保护:2026年9月国务院常务会议审议通过条例草案对外资医药与大健康企业的意义

概述

2026年9月18日,国务院常务会议审议通过《中医药传统知识保护条例(草案)》。官方表述指出,中医药理论、技术和方药是我国自主创新的重要资源,要全面加强保护管理。该草案尚未公布全文。

对在华开展业务或与中国合作的外资医药、医疗健康与大健康企业而言,这一进展具有现实意义:它与2026年已经施行或正在推进的一揽子知识产权举措并列,从新修订《商标法》到《知识产权保护和运用”十五五”规划》,共同影响传统知识、研究协作与品牌资产的记录与维护方式。

本文梳理官方原文表述、条例拟确立的保护制度、规划中的制度安排,以及外资企业可能关注的实务要点,并刻意不作出超出官方记录范围的推断。

2026年9月的决定

国务院常务会议审议通过草案并确定了政策方向。中医药理论、技术和方药被视为我国自主创新的重要资源,任务要求是全面加强保护管理。

条例将建立中医药传统知识保护制度。在该制度下,经登记并审核认定后,持有人享有一组权利:表明身份、传承使用、知情同意、利益分享、完整保护、要求说明来源。

官方表述还鼓励医疗机构主动调查发现中医药验方、秘方和技法,并进行开发研究。

由于全文尚未公布,条款编号、生效日期、登记程序与认定门槛均无从确认。企业宜将此类细节视为待定,直至官方发布为止,不应依赖没有官方出处的描述。

“十五五”规划已作出的安排

该条例草案并非孤立举措。《知识产权保护和运用”十五五”规划》(国发〔2026〕30号,国务院2026年7月27日印发)已把它纳入更宏大的部署。

规划提出加快完善专利相关法律制度,推动商标法及其实施条例全面修改,并出台中医药传统知识保护条例。规划还提出加强传统知识、民间文艺等获取和惠益分享制度建设,完善算法、人工智能生成物以及与平台经济发展相关的知识产权保护规则,并探索构建数据知识产权保护规则。

规划设定了节点目标:到2030年,知识产权综合实力和国际竞争力进一步增强,知识产权强国建设取得决定性进展;展望2035年,知识产权综合竞争力跻身世界前列。

对正在规划中国研究与品牌战略的企业而言,该规划的价值在于,它一次性展示了多项制度工具的共同走向,而不只是一条新规的细节。

2026年相邻的知识产权进展

2026年9月20日,知识产权新规全国巡回宣贯在济南启动,覆盖山东、安徽片区。宣贯围绕三件法规展开。

新修订《商标法》将诚实信用原则写入法律,遏制恶意抢注、囤积商标,严格商标代理监管,强化行业信用约束。该法于2026年6月26日通过,2027年1月1日施行。

新修订《集成电路布图设计保护条例》将集成光子、量子等功能的集成电路布图设计纳入法定保护范围,并建立独创性声明制度。

修订后的《专利优先审查管理办法》使优先审查资源向新兴产业、关键核心技术攻关倾斜,并建立央地协同机制。

与中医药传统知识保护条例合并来看,这些举措指向一个一致的方向:对主张什么、由谁持有、来自何处作出更明确的记录。

对外资医药与大健康企业的实务影响

传统知识尽职调查。 当项目涉及方药、技法或传统知识来源时,官方表述中的权利——表明身份、传承使用、知情同意、利益分享、完整保护、要求说明来源——提示来源与同意问题可能进入记录范围。企业宜留存取得方药或技法的途径与条件的书面材料。

合作协议。 与医院、科研院所及从业者的研究合作应有书面安排,就背景权利与前景权利、发表,以及共同形成成果的处理作出清晰约定。

专利与品牌布局。 规划在专利方面的方向与新修订《商标法》都倾向于奖励尽早且记录充分的申请策略。依赖独特名称与标识的资产组合,宜在新法施行后比照诚实信用与恶意申请相关条款作一次核对。

数字与人工智能相关工作。 规划中关于算法、人工智能生成物与数据知识产权的表述,与数字健康、人工智能辅助筛查及数据驱动研究相关,而这些领域中成果与数据集的归属往往并不确定。

关注官方记录。 由于条例草案尚未公布全文,具体登记路径、认定标准与惠益分享机制仍有待观察。待文本及配套办法发布后,宜重新审视既有规划。

相关考虑

医药与大健康领域的外商投资企业,本就需遵循药品、器械、医疗服务与广告等分行业规则。中医药传统知识保护条例增加的是一个知识保护层面,而非取代上述规则。把两个层面区分开来——可以制造与销售什么,以及可以何种条件使用何种知识——有助于避免把许可问题与市场准入问题混为一谈。

来源

  • 国家知识产权局(《知识产权保护和运用”十五五”规划》专栏):https://www.cnipa.gov.cn/col/col3692/index.html
  • 酒泉市公安局(《知识产权保护和运用”十五五”规划》国发〔2026〕30号全文转载):https://gaj.jiuquan.gov.cn/gaj/c106483/202609/856895252998428d9990e67d9af39108.shtml
  • 国家知识产权局(官网,9月工作动态):https://www.cnipa.gov.cn/?filter=0
  • 大众网滨州(知识产权新规全国巡回宣贯,9月20日济南,9-23):https://www.toutiao.com/article/7688564714451780098/
  • 中国政府网:https://www.gov.cn/

China’s 15th Five-Year Plan for Intelligent Connected NEVs: Targets, Guardrails and What It Means for Foreign Investors

  • Nine departments led by the Ministry of Industry and Information Technology have jointly issued the 15th Five-Year Plan for the Intelligent Connected New Energy Vehicle Industry; the co-issuing bodies are the National Development and Reform Commission, the Ministry of Public Security, the Ministry of Transport, the Ministry of Commerce, the Ministry of Natural Resources, the Ministry of Housing and Urban-Rural Development, the State Administration for Market Regulation and the Cyberspace Administration of China.
    工业和信息化部会同国家发展改革委、公安部、交通运输部、商务部、自然资源部、住房和城乡建设部、市场监管总局、国家网信办(共九部门)联合印发《智能网联新能源汽车产业发展”十五五”规划》。
  • The 2030 targets are that China’s whole-industry-chain advantage in intelligent connected new energy vehicles is further consolidated and the country joins the ranks of the world’s automotive powers; new energy passenger vehicles are to reach 70% of new-vehicle sales in their respective segments and commercial vehicles 40%; and vehicles with autonomous-driving functions are to achieve large-scale application.
    到 2030 年,我国智能网联新能源汽车全产业链优势进一步巩固,进入世界汽车强国行列;国内新能源乘用车在各自领域新车总销量占比达 70%、商用车达 40%;具备自动驾驶功能的汽车实现规模应用。
  • The plan deploys five areas and 17 key tasks — raising technological innovation capability, upgrading the industrial system, promoting cross-sector integration, building a scientific and efficient industry-governance system, and opening a new chapter in global industrial cooperation — supported by four major projects and three priority actions.
    《规划》部署 5 方面 17 项重点任务:提高技术创新能力、推动产业体系优化升级、促进跨界融合发展、构建科学高效的行业治理体系、开创全球产业合作新局面;并配套 4 项重大工程与 3 项重点行动。
  • Capacity early-warning and control is written into an industry five-year plan for the first time: the plan tightens the conditions for establishing independent new energy vehicle makers, speeds up merger-and-reorganisation and the reform of grouped qualification management, and extends capacity control to power batteries by requiring stronger early-warning and control management of power-battery capacity.
    “产能预警调控”首次写入行业五年规划:严格新建独立新能源车企条件,兼并重组、资质集团化管理改革提速,并将产能调控触角延伸至动力电池环节,提出加强动力电池产能预警和调控管理。
  • On 29 September 2026 the Department of Science and Technology of the Ministry of Industry and Information Technology published for comment 29 recommended national standard plan projects, including the Technical Requirements and Test Methods for Supply-Chain Cybersecurity of Intelligent Connected Vehicles; the comment period runs from 30 September to 29 October 2026.
    2026 年 9 月 29 日,工业和信息化部科技司公示《智能网联汽车 供应链网络安全技术要求及试验方法》等 29 项推荐性国家标准计划项目,公示时间为 2026 年 9 月 30 日至 2026 年 10 月 29 日。

China’s 15th Five-Year Plan for Intelligent Connected NEVs: Targets, Guardrails and What It Means for Foreign Investors | 中国智能网联新能源汽车”十五五”规划:目标、护栏与外资含义

Overview

The Intelligent Connected New Energy Vehicle Industry “15th Five-Year Plan” was jointly issued by nine departments, led by the Ministry of Industry and Information Technology. The co-issuing bodies are the National Development and Reform Commission, the Ministry of Public Security, the Ministry of Transport, the Ministry of Commerce, the Ministry of Natural Resources, the Ministry of Housing and Urban-Rural Development, the State Administration for Market Regulation and the Cyberspace Administration of China.

The plan sets the sector’s direction to 2030 across three layers: quantified market-share targets, an organising structure of tasks, projects and actions, and a governance layer that for the first time puts capacity early-warning and control into an industry five-year plan. Running alongside it is a standards programme, of which the most immediately relevant piece is a set of 29 recommended national standard plan projects opened for public comment in late September 2026.

The 2030 targets

By 2030, the plan aims for China’s whole-industry-chain advantage in intelligent connected new energy vehicles to be further consolidated, and for the country to join the ranks of the world’s automotive powers. Two quantified targets anchor the market dimension: new energy passenger vehicles are to account for 70% of new-vehicle sales in their respective segments, and commercial vehicles for 40%. On the technology dimension, the plan states that vehicles with autonomous-driving functions are to achieve large-scale application.

Five areas, 17 tasks, four projects, three actions

The plan deploys five areas and 17 key tasks: raising technological innovation capability; promoting the optimisation and upgrading of the industrial system; advancing cross-sector integrated development; building a scientific and efficient industry-governance system; and opening a new chapter in global industrial cooperation.

Four major projects support those tasks: the intelligent connected new energy vehicle key-technology breakthrough project; the standards and testing-evaluation capability improvement project; the intelligent connected new energy vehicle safety foundation project; and the internationalisation capability upgrade project.

Three priority actions translate the projects into workstreams: the “artificial intelligence plus automobile” development action; the key-component ecosystem development and leading-enterprise cultivation action; and the intelligent connected new energy vehicle application-promotion action.

Capacity early-warning and control enter a five-year plan

The governance layer is where the plan breaks new ground. Capacity early-warning and control is written into an industry five-year plan for the first time. In practice this shows up in three ways: the conditions for establishing independent new energy vehicle makers are tightened; merger and reorganisation and the reform of grouped qualification management are accelerated; and the reach of capacity control is extended to power batteries, with the plan calling for stronger early-warning and control management of power-battery capacity.

For a foreign investor weighing a new greenfield vehicle or battery plant, this is the provision that most directly changes the arithmetic: entry conditions, qualification structure and the capacity conversation are all being moved into a more managed framework.

The standards system: six specialised domains

The plan requires the continued development and improvement of specialised standards systems in six domains: automotive chips, automotive software, data governance and applications, automotive artificial intelligence, automotive solid-state batteries and low-carbon automotive development.

It also addresses market conduct: regulating the release of industry data and information and the payment of enterprise accounts; strengthening market-supervision enforcement; reinforcing anti-monopoly, anti-unfair-competition and price enforcement and justice; and intensifying quality supervision and inspection, defect investigation and product-consistency supervision and inspection.

The 29 draft national standards on supply-chain cybersecurity

On 29 September 2026 the Department of Science and Technology of the Ministry of Industry and Information Technology published for public comment 29 recommended national standard plan projects, among them the Technical Requirements and Test Methods for Supply-Chain Cybersecurity of Intelligent Connected Vehicles. The comment period runs from 30 September to 29 October 2026, and comments are submitted online through the “standards project initiation — project initiation publicity” section of the Ministry of Industry and Information Technology Standards Information Service Platform (https://std.miit.gov.cn).

The drafting of a supply-chain cybersecurity standard for intelligent connected vehicles sits directly under the plan’s automotive-software and automotive-artificial-intelligence standard domains. For suppliers, it is the earliest visible signal of the technical requirements that intelligent connected vehicle supply chains will be expected to meet.

Separately, the State Administration for Market Regulation (Standardization Administration of China) approved and released the national standard on automotive software quality and defect management around 14 September 2026, adding a quality-management counterpart to the technical standards workstream.

Global supply chain and foreign investment cooperation

The plan sets out to build a global industrial chain and supply chain, to improve overseas development service capability, and to support foreign-invested enterprises in investing and cooperating in China.

On 28 September 2026, at the press conference for the 2026 World Intelligent Connected Vehicle Conference, Hao Lishun, deputy director of the First Department of Equipment Industry of the Ministry of Industry and Information Technology, answered questions and set out three areas of work. First, making industrial chain and supply chain cooperation closer — including supporting foreign-invested enterprises in deepening their presence in the Chinese market. Second, deepening international coordination of standards and regulations — actively participating in international standards and regulations activities under mechanisms including the United Nations World Forum for Harmonization of Vehicle Regulations (WP.29), the International Organization for Standardization and the International Electrotechnical Commission, and promoting coordination in the development of standards and regulations for autonomous driving and electric vehicles. Third, making enterprises’ international development more stable — improving supporting arrangements such as cross-border logistics and investment and financing, strengthening overseas risk prevention and corporate compliance, and guiding enterprises to carry out overseas deployment in a prudent and orderly manner.

Judicial rules on AI-related disputes

On 7 September 2026 the Supreme People’s Court of China issued its Opinions on Trying Cases Involving Artificial-Intelligence-Related Disputes, which address liability where a vehicle defect and driver fault cause the same damage, and liability for misleading promotion of a vehicle’s automation level, intelligence, performance or use.

Practical notes for foreign investors

  • Read the capacity layer first. The tightening of conditions for new independent NEV makers and the extension of capacity control to batteries are the provisions that shape whether a new plant is approvable.
  • Track the six standard domains. Automotive chips, software, data governance, automotive AI, solid-state batteries and low-carbon development are the areas where technical requirements will be formalised.
  • Follow the 29 draft standards. Supply-chain cybersecurity is the first of the batch to watch, with comments open until 29 October 2026.
  • Use the cooperation channels. The plan and the 28 September briefing both explicitly support foreign-invested enterprises deepening their China presence and participating in international standards work under WP.29, ISO and IEC.

Sources

  • 工业和信息化部(《智能网联新能源汽车产业发展”十五五”规划》通知): https://www.miit.gov.cn/zwgk/zcwj/wjfb/tz/art/2026/art_47e6f99ffbe945279ef3ffd23c5b3631.html
  • 工业和信息化部科技司(29 项推荐性国家标准计划项目立项公示): https://www.miit.gov.cn/jgsj/kjs/jscx/bzgf/art/2026/art_88f891ce12ee49eabf2a3585eca08ee1.html
  • 工业和信息化标准信息服务平台(标准立项—立项公示): https://std.miit.gov.cn
  • 中国工业新闻网(规划与标准相关报道): https://www.cinn.cn/yc/2026/09-29/LkvqQ7aD.html
  • 上海市人民政府外事办公室(政策转载): https://wsb.sh.gov.cn/ztzl/shzxzb/20260923/3a34c2e581c04aa4a3eb7dafedd9e404.html
  • 国家发展改革委(新闻发布会): https://www.ndrc.gov.cn/xwdt/wszb/9yfbh

Related reading

  • see also: 智能网联新能源汽车”十五五”规划解读(341-nev-15th-fyp-plan)
  • see also: 机动车生产一致性监督检查专项行动(378-vehicle-production-consistency-campaign)

中国智能网联新能源汽车”十五五”规划:目标、护栏与外资含义

概述

《智能网联新能源汽车产业发展”十五五”规划》由工业和信息化部会同国家发展改革委、公安部、交通运输部、商务部、自然资源部、住房和城乡建设部、市场监管总局、国家网信办(共九部门)联合印发。

规划以三个层次界定 2030 年前的方向:量化的市场份额目标;由重点任务、重大工程、重点行动构成的推进结构;以及首次把产能预警调控写入行业五年规划的治理层。与之并行的是标准工作,其中与产业主体最直接相关的一项,是 2026 年 9 月下旬公开征求意见的 29 项推荐性国家标准计划项目。

2030 年目标

规划提出,到 2030 年,我国智能网联新能源汽车全产业链优势进一步巩固,进入世界汽车强国行列。市场维度有两个量化目标锚定:国内新能源乘用车在各自领域新车总销量占比达 70%,商用车达 40%。技术维度上,规划提出具备自动驾驶功能的汽车实现规模应用。

5 方面 17 项任务、4 项工程、3 项行动

规划部署 5 方面 17 项重点任务:提高技术创新能力;推动产业体系优化升级;促进跨界融合发展;构建科学高效的行业治理体系;开创全球产业合作新局面。

4 项重大工程为上述任务提供支撑:智能网联新能源汽车关键技术攻关工程;标准及测试评价能力提升工程;智能网联新能源汽车安全筑基工程;国际化能力跃升工程。

3 项重点行动把工程转化为具体工作流:”人工智能+汽车”发展行动;关键零部件生态建设和领军企业培育行动;智能网联新能源汽车应用推广行动。

产能预警调控首次写入五年规划

治理层是规划的突破之处。”产能预警调控”首次写入行业五年规划。具体体现为三条:严格新建独立新能源车企条件;兼并重组、资质集团化管理改革提速;将产能调控触角延伸至动力电池环节,提出加强动力电池产能预警和调控管理。

对正在评估新建整车或电池工厂的外国投资者而言,这一条最直接地改变测算:准入条件、资质结构与产能议题,都被移入一个更强调管理的框架之中。

标准体系:六个专项领域

规划要求持续建立完善六个专项标准体系:汽车芯片、汽车软件、数据治理及应用、汽车人工智能、车用固态电池、汽车低碳发展。

规划同时规范市场行为:规范行业数据信息发布和企业账款支付;加强市场监管执法;强化反垄断、反不正当竞争和价格执法司法;加强质量监督检查、缺陷调查和产品一致性监督检查力度。

供应链网络安全:29 项国家标准立项公示

2026 年 9 月 29 日,工业和信息化部科技司公示《智能网联汽车 供应链网络安全技术要求及试验方法》等 29 项推荐性国家标准计划项目。公示时间为 2026 年 9 月 30 日至 2026 年 10 月 29 日,意见通过”工业和信息化标准信息服务平台”(https://std.miit.gov.cn)”标准立项—立项公示”栏目在线反馈。

智能网联汽车供应链网络安全标准的立项,正落在规划的汽车软件与汽车人工智能两个标准领域之下。对供应商而言,这是智能网联汽车供应链将要满足的技术要求最早可见的信号。

此外,市场监管总局(国家标准委)于 2026 年 9 月 14 日前后批准发布《汽车软件质量与缺陷管理规范》国家标准,为技术标准工作补充了质量管理维度的对应文件。

全球产业链供应链与外资合作

规划提出构建全球产业链供应链、提升海外发展服务能力、支持外资企业在华投资合作等目标任务。

2026 年 9 月 28 日,在 2026 世界智能网联汽车大会新闻发布会上,工业和信息化部装备工业一司副司长郝立顺答记者问,明确工信部将重点做好三方面工作。其一,推动产业链供应链合作更加紧密,包括支持外资企业深耕中国市场。其二,推动标准法规国际协同更加深入,积极参与联合国世界车辆法规协调组织(WP.29)、国际标准化组织、国际电工委员会等机制下的国际标准法规活动,推动自动驾驶、电动汽车等标准法规制定协调。其三,推动企业国际化发展更加稳健,完善跨境物流、投融资等配套支撑,加强海外风险防范和企业合规建设,引导企业稳妥有序开展海外布局。

涉人工智能纠纷案件的司法规则

2026 年 9 月 7 日,中国最高人民法院发布《关于依法审理涉人工智能纠纷案件的意见》,对车辆缺陷与驾驶人过错行为结合致损的责任,以及对车辆自动化等级、智能程度、性能、用途等作虚假或者引人误解宣传的责任作出规定。

外资企业实务提示

  • 先读产能层。 严格新建独立新能源车企条件,以及产能调控向电池环节延伸,是决定新建工厂能否获批的条款。
  • 跟踪六个标准领域。 汽车芯片、汽车软件、数据治理、汽车人工智能、车用固态电池与汽车低碳发展,是技术要求将被正式化的方向。
  • 关注 29 项立项公示。 供应链网络安全是本批中最值得跟踪的一项,意见反馈开放至 2026 年 10 月 29 日。
  • 用好合作通道。 规划与 9 月 28 日发布会均明确支持外资企业深耕中国市场,并参与 WP.29、ISO、IEC 机制下的国际标准工作。

来源

  • 工业和信息化部(《智能网联新能源汽车产业发展”十五五”规划》通知): https://www.miit.gov.cn/zwgk/zcwj/wjfb/tz/art/2026/art_47e6f99ffbe945279ef3ffd23c5b3631.html
  • 工业和信息化部科技司(29 项推荐性国家标准计划项目立项公示): https://www.miit.gov.cn/jgsj/kjs/jscx/bzgf/art/2026/art_88f891ce12ee49eabf2a3585eca08ee1.html
  • 工业和信息化标准信息服务平台(标准立项—立项公示): https://std.miit.gov.cn
  • 中国工业新闻网(规划与标准相关报道): https://www.cinn.cn/yc/2026/09-29/LkvqQ7aD.html
  • 上海市人民政府外事办公室(政策转载): https://wsb.sh.gov.cn/ztzl/shzxzb/20260923/3a34c2e581c04aa4a3eb7dafedd9e404.html
  • 国家发展改革委(新闻发布会): https://www.ndrc.gov.cn/xwdt/wszb/9yfbh

相关阅读

  • 见:智能网联新能源汽车”十五五”规划解读(341-nev-15th-fyp-plan)
  • 见:机动车生产一致性监督检查专项行动(378-vehicle-production-consistency-campaign)

Foreign-Invested R&D Centres in China: Support Policies, Imported Research Supplies and IP Positioning under the 2026 Action Plan

  • The Action Plan for Stabilising and Optimising Foreign Investment (MOFCOM, NDRC and MOF, document No. 97 of 2026, completed on 16 June 2026 with State Council approval) devotes Part Two, item (7) to vigorously attracting foreign-invested enterprises to establish R&D centres in China.
    《利用外资固稳促优行动方案》(商务部、国家发展改革委、财政部,商资发〔2026〕97号,经国务院同意,2026年6月16日成文)第二部分第(七)条专门规定,大力吸引外资企业在华设立研发中心。
  • The official wording lists five supporting elements: improved support policies, easier introduction of foreign high-level talent, open innovation platforms and practical training bases and new-type R&D institutions, greater support for transforming innovation results, and import tax preferences for scientific research supplies in accordance with law.
    官方原文列出五项支持要素:完善外资研发中心支持政策,便利外籍高层次人才引进,支持设立开放式创新平台和实训基地、发展新型研发机构,加大创新成果转化支持力度,依法享受进口科研用品税收优惠政策。
  • The import-tax element is expressed as “in accordance with law”: the Action Plan affirms the entitlement rather than creating a new concession, and sets out no thresholds, covered-goods list or procedure of its own.
    进口税收环节的表述为”依法享受”:行动方案确认该项待遇,而非另设新的优惠,其本身并未规定门槛、适用物品清单或办理程序。
  • Adjacent provisions widen the downstream routes for results: segmented drug production rules, further pilot regions for biotechnology and wholly foreign-owned hospitals, commercial insurance coverage for more innovative drugs and devices, and platforms easing access to pharmaceutical retail channels.
    相邻条款拓宽了成果的下游路径:药品分段生产实施细则,生物技术与外商独资医院领域试点区域进一步扩大,更多创新药械纳入商业保险保障范围,以及便利进入药品零售渠道的行业协作平台。
  • An R&D centre, a manufacturing company and a regional headquarters carry different licences and supervisory expectations, and the ownership of research results should be settled in employment contracts and inter-company agreements rather than left implicit.
    研发中心、生产性公司与地区总部承载的牌照与监管期待不同;研究成果的归属应在劳动合同与集团间协议中明确,而非留待默认。
  • Technology moving across the border follows classified administration: free-category technology contracts are handled through registration, while restricted-category technology requires licensing.
    跨境技术流动适用分类管理:自由类技术合同通过登记办理,限制类技术需取得许可。

Foreign-Invested R&D Centres in China: Support Policies, Imported Research Supplies and IP Positioning under the 2026 Action Plan | 外资研发中心在华:2026年行动方案下的支持政策、进口科研用品与知识产权布局

Overview

The Action Plan for Stabilising and Optimising Foreign Investment (MOFCOM, NDRC and MOF, document No. 97 of 2026, completed on 16 June 2026 with State Council approval) contains a dedicated measure on R&D centres. Under Part Two, item (7), it calls for vigorously attracting foreign-invested enterprises to establish R&D centres in China, with five supporting elements set out below.

An R&D centre in China is not simply a cost centre attached to a factory. It sits where market access, tax and intellectual property meet, and its value depends on whether research results become assets the group can protect, license and operate. This article sets out the official wording, the tax position of imported research supplies, how a centre differs from a factory or a regional headquarters, and the steps that turn a research presence into a productive one.

The measure in the 2026 Action Plan

The provision is short and programmatic, with five building blocks:

  • Improving support policies for foreign R&D centres. The Plan does not restate the criteria; it directs that the support framework be improved.
  • Facilitating the introduction of foreign high-level talent. Talent mobility is part of the R&D-centre package, linking the measure to the work-permit and talent-administration regime.
  • Supporting open innovation platforms, practical training bases and new-type R&D institutions. This recognises centres that collaborate with universities, institutes and industrial partners rather than operating as closed corporate laboratories.
  • Increasing support for the transformation of innovation results. Commercialisation, not only discovery, is written into the measure.
  • Enjoying import tax preferences for scientific research supplies in accordance with law. The Plan affirms the entitlement by reference to the applicable law rather than creating a concession of its own.

Two adjacent provisions frame the demand side. Part One, item (1), on services-sector opening, calls for steadily expanding pilot openings for vocational-skills training institutions, vocational colleges and high-level science, engineering, agriculture and medical universities, and for supporting Beijing’s national comprehensive demonstration zone for services opening, with pioneering measures in the digital economy and healthcare. Part One, item (3) calls for promptly issuing implementation rules for segmented drug production, seeking approval to further expand pilot regions for biotechnology and wholly foreign-owned hospitals, supporting insurers in bringing more innovative drugs and devices into commercial insurance coverage, and building platforms that ease the entry of foreign-invested enterprises’ drugs into pharmaceutical retail channels.

Imported research supplies: what “in accordance with law” means in practice

The import-tax element is deliberately general. The Plan affirms that foreign R&D centres may “enjoy import tax preferences for scientific research supplies in accordance with law”, and sets out no thresholds, covered-goods list or procedure of its own. Those details live in the import tax policy for scientific and technological innovation and in the provincial qualification review measures that implement it.

The consequence is procedural rather than interpretive. A centre intending to rely on the preference should confirm with the competent commerce, finance, customs and tax authorities the framework in force and the applicable qualification criteria. It should keep documentary evidence of its research substance — investment or research input, full-time research personnel, equipment purchased — because qualification is assessed against such indicators rather than the centre’s name. It should also verify item by item that the goods it wishes to import meet the applicable conditions, since the preference is bounded by those conditions rather than being a general exemption.

R&D centre, factory and regional headquarters: three different positions

A manufacturing company holds production-related licences and is assessed on output, quality and environmental performance; a regional headquarters is mainly a management, co-ordination and shared-service vehicle; an R&D centre is oriented to research and to the transformation of results. The difference matters in three places.

Licensing and approvals. The approvals, filings and supervisory expectations for a research entity differ from those for a production entity. A group planning to move a project from laboratory to pilot to production should design the entity chain in advance rather than assume that the R&D entity can carry the whole pipeline.

Intellectual-property ownership. Results created by employees in the course of their work raise questions of ownership and reward, which should be settled in employment contracts and internal rules and, where group companies are involved, in inter-company agreements on ownership, licensing and transfer.

Technology flows across the border. China administers technology import and export through classified management: free-category technology contracts are handled through registration, restricted-category technology requires licensing. A centre licensing technology to its overseas parent, or introducing technology from abroad, should complete the applicable formalities; the classification of the specific technology determines the route.

Turning results into protectable, operable assets

Patent layout. Filing strategy should be part of project design — deciding early which results are filed, where and in whose name. The revised Measures for the Prioritised Examination of Patents (State Intellectual Property Office Order No. 85), published on 28 July 2026 and effective from 1 September 2026, replaced the 2017 measures and steer fast-track examination toward high-quality applications serving emerging and future industries. For a portfolio concentrated in such fields, prioritised examination is one available accelerator; the substantive requirements and the grounds on which it will not be granted should be checked against the current measures, and the service carries no additional fee.

Contractual architecture. Collaboration with universities, institutes and partners should be documented, with clarity on background and foreground rights, publication and the treatment of jointly created results.

Commercialisation pathway. The emphasis on result transformation, read with the healthcare openings above, suggests that centres should plan the downstream route from the outset: pilot and scale-up capacity, approvals, and the commercial channels available.

Service safeguards

The Plan also addresses what happens after a project lands: it calls for fully implementing national treatment for foreign-invested enterprises and for a special rectification campaign in government procurement to remove barriers; it strengthens the “Invest in China” brand, provides for monthly roundtable meetings with foreign-invested enterprises, and establishes dedicated task forces for key foreign investment projects to provide “point-to-point” service.

Practical steps

  1. Read item (7) with items (1) and (3), which determine where results can go.
  2. Settle the entity design — R&D, pilot and production entities, and any regional headquarters — and map licences accordingly.
  3. Document the centre’s research substance from the start, so that qualification reviews rest on evidence rather than assertion, and confirm the current import-tax policy and its conditions before committing to equipment purchases.
  4. Write intellectual-property arrangements into employment contracts and inter-company agreements, covering ownership, licensing, transfer and cross-border technology flows.

Related reading

  • The Action Plan for Stabilising and Optimising Foreign Investment (document No. 97 of 2026).

Sources

  • 湖南省人民政府(《利用外资固稳促优行动方案》官方英文全文,含第(七)条研发中心原文): https://www.hunan.gov.cn/zqt/zcsd/202607/34034823/files/7660c23769ae4f51ac21a456fe4e0ea5.pdf
  • 江苏省知识产权局(关于修改《专利优先审查管理办法》的说明): https://jsip.jiangsu.gov.cn/art/2026/9/20/art_76183_11832138.html
  • 浙江省市场监督管理局(国家知识产权局关于做好《专利优先审查管理办法》有关实施工作的通知): https://zjamr.zj.gov.cn/col/col1229094027/art/2026/art_c86f0eda26b8439d806be9a748519f47.html
  • 国家知识产权局(官网): https://www.cnipa.gov.cn/
  • 商务部(官网): https://www.mofcom.gov.cn/

外资研发中心在华:2026年行动方案下的支持政策、进口科研用品与知识产权布局

概述

《利用外资固稳促优行动方案》(商务部、国家发展改革委、财政部,商资发〔2026〕97号,经国务院同意,2026年6月16日成文)中就研发中心设有专门条款。方案第二部分第(七)条提出,大力吸引外资企业在华设立研发中心,并列出以下五项支持要素。

对外资集团而言,在华研发中心并非附属于工厂的成本单元。它处在市场准入、税收与知识产权三条政策线的交汇处,其价值取决于研究成果能否转化为集团可保护、可许可、可运营的资产。本文梳理该条官方原文、进口科研用品的税收位置、研发中心与生产实体及地区总部在牌照与知识产权层面的差异,以及把研发存在变成研发产出的实务步骤。

2026年行动方案中的该条内容

该条文字简短、方向明确,由五个要素构成:

  • 完善外资研发中心支持政策。 方案本身未重述具体标准,而是要求把支持政策框架加以完善。
  • 便利外籍高层次人才引进。 人才流动被纳入研发中心政策的整体安排,与工作许可、人才管理等制度相衔接。
  • 支持设立开放式创新平台、实训基地,发展新型研发机构。 这认可了研发中心与高校、科研院所、产业伙伴协作的模式,而非仅作为封闭的企业实验室运行。
  • 加大创新成果转化支持力度。 转化与发现并重,被写入条款之中。
  • 依法享受进口科研用品税收优惠政策。 方案以援引现行法律的方式确认该项待遇,而非另行创设一项新的优惠。

两条相邻条款界定了需求侧。第一部分第(一)条关于深化服务业领域开放,提出稳步扩大职业技能培训机构、职业院校、高水平理工农医类大学对外开放试点;支持北京提升国家服务业扩大开放综合示范区建设水平,推动数字经济、医药健康等现代服务业重点领域开放举措先行先试。第一部分第(三)条关于支持外资参与医药等产业高质量发展,提出抓紧研究出台药品分段生产实施细则;抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围;支持保险公司将更多创新药械纳入商业保险保障范围;搭建行业协作平台,便利外资企业生产的药品进入药品零售渠道。

进口科研用品:”依法享受”在实务中的含义

该条中的进口税收要素刻意保持概括。方案确认外资研发中心可”依法享受进口科研用品税收优惠政策”,其本身并未规定门槛、适用物品清单或办理程序。这些细节由支持科技创新的进口税收政策及其配套的省级资格审核办法承载。

因此,实务上的后果是程序性的,而非解释性的。拟适用该待遇的中心,应先与商务、财政、海关与税务主管部门确认现行有效的政策框架与适用资格条件;应保存体现研发实质的证明材料——投资额或研发投入、专职研发人员、累计购置设备——因为资格是按此类指标而非按中心名称判定的;还应逐项核实拟进口物品是否满足适用条件,因为该待遇以这些条件为边界。

研发中心、工厂与地区总部:三种不同位置

生产性公司持有与生产相关的牌照,考核的是产量、质量与环境表现。地区总部主要是管理、协调与共享服务载体。研发中心则面向研究以及成果转化。差异体现在三处。

牌照与审批。 研发主体所适用的审批、备案与监管期待,与生产主体并不相同。计划把项目从实验室推进到中试再到生产的集团,应提前设计主体链条,而不是假定研发主体能够承载整条链路。

知识产权归属。 员工在职完成的成果,其归属与奖酬问题应在劳动合同与内部制度中厘清;涉及集团内公司时,还应在公司间协议中就归属、许可与转让作出约定。若相关安排对此保持沉默,将给集团的全球资产组合带来本可避免的不确定性。

跨境技术流动。 中国对技术进出口实行分类管理:自由类技术合同通过登记办理,限制类技术需取得许可。研发中心向境外母公司许可技术,或从境外引进技术时,应完成相应手续;具体技术的类别决定适用路径。

让成果成为可保护、可运营的资产

专利布局。 申请策略应作为项目设计的组成部分——尽早确定哪些成果申请、在哪里申请、以谁的名义申请。新修订《专利优先审查管理办法》(国家知识产权局令第八十五号)于2026年7月28日公布、自2026年9月1日起施行,取代2017年发布的原办法,优先审查资源向服务新兴产业和未来产业领域的高质量申请倾斜。对于资产组合集中于此类领域的中心,优先审查是可用的一条加速通道;实质性条件以及不予优先审查的情形,应比照现行办法核对,且该服务不收取额外费用。

合同架构。 与高校、科研院所及伙伴开展的协作应有书面安排,就背景权利与前景权利、发表以及共同形成成果的处理作出清晰约定。

转化路径。 方案对成果转化的强调,结合前述医药领域的开放举措,提示中心应从一开始就考虑下游路径——中试与放大能力、所需审批,以及成果产品可用的商业渠道。

服务保障

方案也涉及项目落地之后的事项:全面落实外资企业国民待遇,开展政府采购领域专项整治破除壁垒;强化”投资中国”品牌,每月召开外资企业圆桌会议,并建立重点外资项目工作专班提供”点对点”服务。

实务步骤

  1. 把第(七)条与第(一)条、第(三)条结合阅读,后者决定成果可去向何处。
  2. 先确定主体设计——研发主体、中试与生产主体,以及可能的地区总部——并据此梳理牌照。
  3. 从一开始就记录中心的研发实质,使资格审核以证据而非主张为支撑;并在承诺设备采购之前,与主管部门确认现行进口税收政策及其适用条件。
  4. 把知识产权安排写入劳动合同与公司间协议,覆盖归属、许可、转让与跨境技术流动。

相关阅读

  • 《利用外资固稳促优行动方案》(商资发〔2026〕97号)。
  • 新修订《专利优先审查管理办法》(局令第八十五号)。

来源

  • 湖南省人民政府(《利用外资固稳促优行动方案》官方英文全文,含第(七)条研发中心原文):https://www.hunan.gov.cn/zqt/zcsd/202607/34034823/files/7660c23769ae4f51ac21a456fe4e0ea5.pdf
  • 江苏省知识产权局(关于修改《专利优先审查管理办法》的说明):https://jsip.jiangsu.gov.cn/art/2026/9/20/art_76183_11832138.html
  • 浙江省市场监督管理局(国家知识产权局关于做好《专利优先审查管理办法》有关实施工作的通知):https://zjamr.zj.gov.cn/col/col1229094027/art/2026/art_c86f0eda26b8439d806be9a748519f47.html
  • 国家知识产权局(官网):https://www.cnipa.gov.cn/
  • 商务部(官网):https://www.mofcom.gov.cn/

AI-Related Inventions and Trademark Evidence in China: The September 2026 Examination Standards

  • China’s new Patent Examination Guidelines, in force since 1 January 2026, require that the inventor be a natural person and that an artificial-intelligence system may not be named as an inventor; the guidelines also establish a “holistic determination” approach to assessing patentable subject matter.
    自2026年1月1日施行的新版《专利审查指南》要求发明人必须是自然人,请求书中不得填写人工智能名称,并确立了判断专利保护客体的”整体判断”原则。
  • The Supreme People’s Court’s Opinion on adjudicating artificial-intelligence-related disputes, issued on 7 September 2026, provides in Article 14 that an AI-related invention which “adopts technical means that follow the laws of nature, solves a technical problem and achieves a technical effect consistent with the laws of nature” is protected as a patent-eligible subject matter; the protection is for human creativity, not machine output.
    最高人民法院于2026年9月7日发布的《关于依法审理涉人工智能纠纷案件的意见》第14条明确:涉人工智能发明创造”采用遵循自然规律的技术手段,解决了技术问题,实现了符合自然规律的技术效果的”,依法认定为专利法所保护的客体;专利保护的是人的创造性,而非机器的产出。
  • The administrative rules and the judicial rules now converge for the first time on the question of AI inventions: both insist that patent protection attaches to human inventiveness, while leaving the door open for AI-assisted technical solutions that meet the three-element test of means, problem and effect.
    行政审查规则与司法裁判规则在人工智能发明创造问题上首次形成呼应:二者均强调专利保护指向人的创造性,同时为满足”手段—问题—效果”三要素的人工智能辅助技术方案保留通道。
  • The 15th Five-Year Plan for intellectual-property protection and utilisation calls for improving the protection rules for algorithms, artificial-intelligence-generated outputs and matters related to platform-economy development, signalling a forward-looking policy direction for AI-related IP.
    《知识产权保护和运用”十五五”规划》提出”完善算法、人工智能生成物以及与平台经济发展相关的知识产权保护规则”,为人工智能相关知识产权指明了前瞻性政策方向。
  • The revised Measures for the Prioritised Examination of Patents (Order No. 85) took effect on 1 September 2026, steering fast-track resources toward emerging industries, future industries and key-core-technology breakthroughs; a 26 August 2026 implementation notice clarifies the transition between the old and new regimes.
    新修订《专利优先审查管理办法》(局令第85号)自2026年9月1日起施行,优先审查资源向新兴产业、未来产业和关键核心技术攻关倾斜;2026年8月26日的实施工作通知明确了新旧办法的衔接安排。
  • In trademark practice, the “three-year non-use cancellation” procedure is placing greater weight on electronically admissible evidence that forms a traceable, mutually corroborating chain — contracts, orders, payments, logistics, platform pages and promotional records — narrowing the room for fabricated transaction invoices or formalistic orders to manufacture a veneer of use.
    商标审查中的”连续三年不使用撤销”程序更加重视可采信的电子证据,强调形成可追溯、相互印证的完整链条(合同、订单、付款、物流、平台页面、宣传记录),压缩了以虚假交易发票或形式化订单制造”使用痕迹”的空间。
  • Practical compliance for foreign innovators and brand owners means documenting the human contribution in AI-assisted filings, retaining R&D and data-source trail, preparing a use-evidence archive per mark, and building a defensible evidence chain before any cancellation challenge arises.
    对境外创新主体与品牌权利人而言,实务合规意味着在人工智能辅助申请中记录人的贡献、留存研发与数据来源痕迹、为核心商标建立使用证据档案,并在面临撤销挑战前构建可抗辩的证据链。

AI-Related Inventions and Trademark Evidence in China: The September 2026 Examination Standards | 人工智能相关发明创造的专利确权边界与商标使用证据要求(2026年9月)/ AI-Related Inventions and Trademark Evidence in China

Overview

September 2026 is a notable moment for intellectual-property protection in China: within the same year, the administrative and judicial branches have both drawn the boundary around artificial-intelligence-related creations so as to protect human inventiveness while accommodating AI-assisted technical solutions. The revised Patent Examination Guidelines in force since 1 January 2026 set out who may be named as an inventor and how patentable subject matter is assessed. The Supreme People’s Court’s Opinion on adjudicating AI-related disputes, released on 7 September 2026, gives courts a dedicated rule — Article 14 — on when an AI-related invention is patent-eligible. Around this core, the 15th Five-Year Plan for IP protection (state document No. 30 of 2026) sets a forward-looking direction, the revised Measures for the Prioritised Examination of Patents (Order No. 85) took effect on 1 September 2026, and trademark use-evidence standards are tightening in practice. The combined message for foreign filers: protect and prove human creativity, and keep the documentary trail that demonstrates it.

Administrative examination: the inventor must be human

The revised Patent Examination Guidelines, effective from 1 January 2026, address artificial intelligence directly. First, the inventor must be a natural person; the request form may not list an AI system as an inventor. The legal status of “inventor” is reserved for human beings, and an AI tool is treated as an instrument of the human inventor. Second, the guidelines establish a “holistic determination” (整体判断) principle: the examiner weighs the invention as a whole against the statutory criteria rather than isolating a single feature. This matters for AI-related applications, where the contribution may lie in how a model, algorithm or data pipeline is applied to a concrete technical problem. Applicants should present the solution as an integrated technical whole, not as a bare claim to an abstract idea or to a machine’s output, and should ensure the named inventors are identifiable natural persons.

Judicial stance: the Supreme People’s Court Opinion of September 2026

On 7 September 2026, the Supreme People’s Court issued the Opinion on Adjudicating Cases Involving Disputes over Artificial Intelligence, the first judicial adjudication rule document on AI issued by the country’s highest judicial organ. Its Part Three (Articles 12–16) deals specifically with IP disputes, covering infringement liability, open-source software, patent grant and validity, technology-contract performance and data-use norms.

Article 14 is the provision most directly relevant to patents. It provides that an AI-related invention which “adopts technical means that follow the laws of nature, solves a technical problem and achieves a technical effect consistent with the laws of nature” is, pursuant to law, a subject matter protected by the patent law. The test is the familiar three-element inquiry — technical means, technical problem, technical effect — applied to AI-related subject matter, and the Opinion makes explicit that the patent system protects human creativity, not machine output. This aligns the judicial threshold with the administrative “holistic determination” principle, gives courts a stable published rule, and closes the gap that had existed between how examiners and judges might treat AI-assisted inventions.

Policy layer and prioritised examination

The 15th Five-Year Plan for the Protection and Utilisation of Intellectual Property (State Council document No. 30 of 2026, issued on 27 July 2026) calls for improving protection rules for algorithms, AI-generated outputs and platform-economy matters, and for continuously improving patent-related legal systems. It signals that AI-related IP rules are still being built, on a trajectory of clearer, more purposive protection rather than exclusion.

The revised Measures for the Prioritised Examination of Patents (Order No. 85), effective from 1 September 2026, replace the 2017 version and steer fast-track resources toward high-value applications — those involving emerging industries, future industries or key-core-technology breakthroughs, or industries encouraged by provincial or city-level governments, among other grounds — while imposing sanctions for conduct violating the principle of good faith. A 26 August 2026 implementation notice clarifies the transition: requests submitted from 1 September 2026 follow the new Measures, earlier ones follow the original; re-examination or invalidation prioritised-examination requests are filed online via the “patent事务服务” module of the patent business-processing system; and the new Prioritised Examination Request form applies from 1 September 2026.

Trademark side: use evidence and the three-year non-use cancellation

On the trademark front, the “three-year non-use cancellation” procedure (撤三) is where evidentiary discipline is tightening most visibly. A registered mark not genuinely used for three consecutive years without proper reason may be cancelled on petition, and examination now places greater weight on electronically admissible materials that form a traceable, mutually corroborating chain: a contract, its order, the payment record, the logistics proof, the platform listing and the promotional record should each corroborate the others. An isolated invoice is no longer enough; fabricated transaction invoices, formalistic orders lacking real performance, or defensive “affiliation” arrangements meant merely to manufacture a semblance of use are being squeezed out.

This direction is reinforced by the revised Trademark Law, adopted on 26 June 2026 and taking effect on 1 January 2027 — the first comprehensive amendment since 1983. It writes the principle of good faith into the statute, tightens the registration gate against hoarding and squatting, and strengthens supervision of trademark agencies. For foreign brand owners, stricter use-evidence expectations plus a good-faith statutory regime mean documented, genuine commercial use is the safest way both to keep a mark alive and to defeat a non-use cancellation petition.

Practical steps for applicants

For AI-related patent filings: (1) record the human contribution — ensure named inventors are natural persons and keep internal logs of who directed and performed the inventive work; (2) draft to the three-element test, articulating technical means, problem and effect as an integrated solution; (3) retain the R&D and data-source trail, documenting provenance and licences of any training data; (4) prepare office-action responses early, assembling search reports and prior-art material to show, holistically, why the solution is a lawful technical contribution.

For trademark protection: (1) build a use-evidence archive per core mark, keeping dated contracts, orders, payments, logistics, platform listings and promotional materials; (2) make the chain self-corroborating with independent sources such as platform pages or customs records; (3) tie defensive registrations to real commercial plans, since filings beyond normal business needs carry rejection and bad-faith risk; (4) prepare the cancellation-defence package in advance rather than waiting for a 撤三 petition.

Related reading

  • The revised Patent Examination Guidelines (effective 1 January 2026) on inventor status and subject-matter assessment.
  • The Supreme People’s Court Opinion on adjudicating AI-related disputes (7 September 2026), Part Three on IP disputes.
  • The 15th Five-Year Plan for the Protection and Utilisation of Intellectual Property (State Council document No. 30 of 2026).
  • The revised Measures for the Prioritised Examination of Patents (Order No. 85, effective 1 September 2026).

Sources

  • 国家知识产权局(官网): https://www.cnipa.gov.cn/
  • 林州市人民政府(新版《专利优先审查管理办法》全文转载): https://www.linzhou.gov.cn/2026/09-07/3658810.html
  • 浙江省市场监督管理局(浙江省知识产权局)《关于做好〈专利优先审查管理办法〉有关实施工作的通知》转载: https://zjamr.zj.gov.cn/col/col1229094027/art/2026/art_c86f0eda26b8439d806be9a748519f47.html
  • 最高人民法院(官网): https://www.court.gov.cn/
  • 最高人民法院知识产权法庭《以人为本 智能向善——聚焦〈最高人民法院关于依法审理涉人工智能纠纷案件的意见〉》: https://ipc.court.gov.cn/zh-cn/news/view-6036.html
  • 国家知识产权局《国务院关于印发〈知识产权保护和运用”十五五”规划〉的通知》(国发〔2026〕30号): https://www.cnipa.gov.cn/art/2026/7/31/art_3693_207456.html

人工智能相关发明创造的专利确权边界与商标使用证据要求(2026年9月)/ AI-Related Inventions and Trademark Evidence in China

概述

2026年9月对中国知识产权保护是一个值得关注的节点:行政与司法两个层面在同一年内就人工智能相关创造的边界作出呼应——既保护人的创造性,又为人工智能辅助的技术方案留出空间。自2026年1月1日施行的新版《专利审查指南》明确了谁可被列为发明人,以及如何判断专利保护客体。最高人民法院于2026年9月7日发布的《关于依法审理涉人工智能纠纷案件的意见》首次为法院提供专门规则——第14条,界定涉人工智能发明创造何时构成专利法所保护的客体。围绕这一核心,《知识产权保护和运用”十五五”规划》(国发〔2026〕30号)指明前瞻方向,新修订《专利优先审查管理办法》(局令第85号)自2026年9月1日起施行,商标使用证据标准在实践中持续收紧。对在华提交申请的外国申请人而言,综合信号很明确:保护并证明人的创造性,并保留能够证明这一点的文档痕迹。

行政审查:发明人必须是人

自2026年1月1日施行的新版《专利审查指南》正面回应人工智能问题。第一,发明人必须是自然人,请求书中不得填写人工智能系统作为发明人——”发明人”的法律地位专属于自然人,无论多先进的人工智能工具都只是人类发明人的器具。第二,指南确立”整体判断”原则:审查员将发明作为一个整体与法定要件衡量,而非孤立看待单一特征。这一点对人工智能相关申请尤为关键,其贡献可能体现在模型、算法或数据管线如何被应用于具体技术问题。申请人应将方案作为一体化技术整体呈现,而非对抽象思想或机器产出的简单主张,并确保列名发明人为可识别的自然人。

司法立场:最高人民法院2026年9月意见

2026年9月7日,最高人民法院发布《关于依法审理涉人工智能纠纷案件的意见》,是国家最高审判机关发布的首部涉人工智能司法裁判规则文件。其第三部分(第12至16条)专述知识产权纠纷,涵盖侵权责任认定、开源软件法律责任、专利授权确权、技术合同履行及数据使用规范。

第14条是与专利关系最直接的条款,明确:涉人工智能发明创造”采用遵循自然规律的技术手段,解决了技术问题,实现了符合自然规律的技术效果的”,依法认定为专利法所保护的客体。适用的仍是熟悉的三要素检验——技术手段、技术问题、技术效果——并应用于人工智能相关客体;意见同时明确,专利制度保护的是人的创造性,而非机器的产出。这使司法门槛与行政”整体判断”原则对齐,为法院提供稳定、公开的裁判规则,并弥合了审查员与法官在对待人工智能辅助发明上可能存在的分歧。

政策层与优先审查

《知识产权保护和运用”十五五”规划》(国发〔2026〕30号,2026年7月27日印发)提出”完善算法、人工智能生成物以及与平台经济发展相关的知识产权保护规则”,并承诺持续完善专利相关法律制度。它释放出信号:人工智能相关知识产权的规则仍在构建之中,走向是更清晰、更有针对性的保护,而非简单排斥。

新修订《专利优先审查管理办法》(局令第85号)自2026年9月1日起施行,取代2017年版,将快车道资源导向高价值申请——涉及新兴产业、未来产业或关键核心技术攻关,或省级、设区的市级人民政府重点鼓励产业等情形——并对违反诚信原则的行为设定罚则。2026年8月26日的实施工作通知明确衔接:自9月1日起提交的优先审查请求按新办法办理,此前已提交的按原办法办理;复审或无效宣告案件的优先审查请求通过”专利业务办理系统”的”专利事务服务”模块线上办理;自9月1日起适用新版《专利优先审查请求书》表格。

商标侧:使用证据与”连续三年不使用撤销”

商标领域,”连续三年不使用撤销”(”撤三”)程序的证据纪律收紧得最为明显。注册商标无正当理由连续三年未真实使用的,可经请求被撤销;审查如今更重视可采信的电子材料,强调形成可追溯、相互印证的完整链条:一份合同、对应订单、付款记录、物流凭证、平台在售页面与宣传记录应彼此印证。一张孤立发票已不足够;虚假交易发票、缺乏真实履行的形式化订单,或仅为制造”使用痕迹”而设的防御性挂靠安排,正被持续挤出。

这一方向得到新修订《商标法》的强化。该法于2026年6月26日通过,自2027年1月1日起施行,是1983年施行以来的首次全面修订。修订将诚实信用原则写入法律文本,收紧注册入口以遏制囤积与抢注,并强化对商标代理机构的监管。对境外品牌权利人而言,更严格的使用证据期待叠加诚信法定原则,意味着有据可查的真实商业使用,是维持商标存续、击退”撤三”请求最稳妥的方式。

申请人实务要点

人工智能相关专利申请:一是记录人的贡献——确保列名发明人为自然人,并保留谁主导、谁完成创造性工作的内部记录;二是围绕三要素撰写,将技术手段、问题与效果作为一体化方案阐明;三是留存研发与数据来源痕迹,记录训练数据的来源与授权;四是提前备妥审查意见答复材料,用检索报告与现有技术材料从整体上说明方案为何构成合法技术贡献。

商标保护:一是为核心商标建立使用证据档案,保存带日期的合同、订单、付款、物流、平台在售信息与宣传材料;二是以平台页面、海关记录等独立来源使证据链自我印证;三是将防御性注册与实际商业规划挂钩,明显超出正常经营需要的申请有驳回与恶意认定风险;四是提前备好撤销答辩材料,而非待”撤三”请求来临才着手。

相关阅读

  • 新版《专利审查指南》(2026年1月1日施行)关于发明人地位与客体判断的规定。
  • 最高人民法院《关于依法审理涉人工智能纠纷案件的意见》(2026年9月7日),第三部分专述知识产权纠纷。
  • 《知识产权保护和运用”十五五”规划》(国发〔2026〕30号)。
  • 新修订《专利优先审查管理办法》(局令第85号,2026年9月1日施行)。

来源

  • 国家知识产权局(官网):https://www.cnipa.gov.cn/
  • 林州市人民政府(新版《专利优先审查管理办法》全文转载):https://www.linzhou.gov.cn/2026/09-07/3658810.html
  • 浙江省市场监督管理局(浙江省知识产权局)《关于做好〈专利优先审查管理办法〉有关实施工作的通知》转载:https://zjamr.zj.gov.cn/col/col1229094027/art/2026/art_c86f0eda26b8439d806be9a748519f47.html
  • 最高人民法院(官网):https://www.court.gov.cn/
  • 最高人民法院知识产权法庭《以人为本 智能向善——聚焦〈最高人民法院关于依法审理涉人工智能纠纷案件的意见〉》:https://ipc.court.gov.cn/zh-cn/news/view-6036.html
  • 国家知识产权局《国务院关于印发〈知识产权保护和运用”十五五”规划〉的通知》(国发〔2026〕30号):https://www.cnipa.gov.cn/art/2026/7/31/art_3693_207456.html

China’s patent fast-track gets a 2026 reset: new Prioritised Examination Measures effective 1 September

  • The China National Intellectual Property Administration (CNIPA) published the revised Measures for the Prioritised Examination of Patents (Order No. 85), adopted at its 4th bureau meeting on 16 July 2026 and effective from 1 September 2026, repealing the 2017 version (Order No. 76).
    国家知识产权局公布新修订《专利优先审查管理办法》(局令第85号):2026年7月16日经第4次局务会议审议通过、7月28日公布,自2026年9月1日起施行,2017年版(局令第76号)同时废止。
  • The scope of prioritised examination now covers invention applications in substantive examination that have not yet received a first office action, utility-model and design applications, and re-examination and invalidation cases — while fast-track channels via bilateral/multilateral agreements or IP protection centres are expressly excluded.
    优先审查适用范围涵盖处于实质审查阶段且未作出首次处理的发明专利申请、实用新型和外观设计专利申请,以及复审案件和无效宣告案件;依据双边或多边协议开展优先审查、或经知识产权保护中心预审合格快速审查的,按有关规定处理,不适用本办法。
  • Eligibility for priority centres on innovation value and transformation prospects: emerging and future industries or key-core-technology breakthroughs, industries encouraged by provincial or municipal governments, applicants already industrialising or ready to industrialise (or evidence that others are implementing the invention), first-filing-in-China applications later filed abroad with substantive-examination requests, and other cases of major national or public interest.
    优先审查的适格条件聚焦创新价值与转化前景:涉及新兴产业和未来产业或关键核心技术攻关;涉及省级或设区的市级人民政府重点鼓励的产业;申请人已产业化实施或已做好实施准备、或有证据证明他人正在实施;就相同主题首次在中国申请后又向其他国家或地区提出实质审查请求的;对国家利益或公共利益具有重大意义的其他情形。
  • Reform highlights include tighter management with central-local co-ordination, quality-oriented handling that disciplines violation of good-faith principles, and procedure-level convenience: electronic XML filing, no extra fees for prioritised examination, and clarified processing rules.
    本次修改突出:强化央地协同、规范省级推荐管理;质量导向,对违反诚信原则行为设罚则;程序便利化——采用XML格式电子申请、优先审查不收取额外费用、优化办理手续。
  • For foreign applicants, the key practical point is territorial eligibility: for applications and re-examination requests, the first applicant’s address must be within China (provincial IP offices recommend); overseas and Taiwan-China-region applicants requesting prioritised examination must show the application positively promotes the province’s industrial upgrading and technical iteration, and file in paper form where required.
    对外国申请人最关键的实际要点是地域适格:专利申请与复审案件请求优先审查,第一申请人地址须在中国境内(由省级知识产权局推荐);境外及中国台湾地区申请人提出请求的,其专利申请应对本省产业升级、技术迭代有积极促进作用,且按规定以纸件方式提出。

China’s patent fast-track gets a 2026 reset: new Prioritised Examination Measures effective 1 September | 专利”快车道”2026版重启:新《专利优先审查管理办法》9月1日施行

Overview

On 28 July 2026, the China National Intellectual Property Administration (CNIPA) published the revised Measures for the Prioritised Examination of Patents (《专利优先审查管理办法》) as Order No. 85, adopted at the 4th CNIPA bureau meeting on 16 July 2026. The Measures took effect on 1 September 2026, replacing the 2017 version (Order No. 76). Prioritised examination is China’s formal fast-track within the ordinary examination system — distinct from the PPH-style channels under bilateral/multilateral agreements and from pre-examination-based fast channels at intellectual-property protection centres — and the revision rebalances eligibility, tightens management and modernises procedure. For foreign patent applicants with Chinese filings, the changes affect who can ask for the fast track, how the request is made, and what supporting evidence is expected.

What the revised scope covers

Under the new Measures, prioritised examination applies to:

  • invention applications that are in substantive examination and have not yet received a first office action (首次处理, i.e. the examiner has begun examination and issued a notification);
  • utility-model and design applications;
  • re-examination cases for invention, utility-model and design patents; and
  • invalidation cases for invention, utility-model and design patents.

Expressly outside the Measures are prioritised examination conducted under bilateral or multilateral agreements between CNIPA and foreign offices, and fast-track examination of applications that have passed pre-examination at a national IP-protection centre or rapid-rights-protection centre — those follow their own rules.

The five eligibility grounds

An applicant or re-examination requester may request prioritised examination where the application or case has significant innovation value and transformation prospects and falls under one of five categories:

  1. Emerging and future industries, or key-core-technology breakthroughs (新兴产业和未来产业,或者关键核心技术攻关);
  2. industries encouraged by a provincial or city-level government (省级或设区的市级人民政府重点鼓励的产业);
  3. the applicant has already industrialised or prepared to industrialise, or there is evidence that others are implementing the invention;
  4. the application was first filed in China and a substantive-examination request is later made in another country or region for the same subject matter (a Chinese priority-anchor case); and
  5. other circumstances of major significance to national or public interests.

For invalidation cases, either the invalidation requester or the patentee may request prioritised examination in listed circumstances, including where the patent is involved in infringement disputes and a local IP administration or court is handling the matter.

What changed: three reform themes

1. Adjusted eligibility to serve national priorities. The revision sharpens the focus on high-quality applications in emerging and future industries, adapts the scope to the amended Patent Law and its implementing rules, clarifies circumstances in which prioritised examination will not be granted, and anchors the regime to supporting new-quality productive forces and an innovation-friendly business environment.

2. Full-lifecycle management with a quality orientation. Institutionally, the Measures strengthen central-local co-ordination: CNIPA manages prioritised examination nationwide, receives requests recommended by relevant State Council departments, and reinforces review-resource guarantees; provincial IP offices handle recommendation of requests in their regions and are guided to strengthen management of requesting entities and provide targeted services. In examination organisation, acceptance, review and examination stages are more tightly regulated to raise quality and efficiency. At the source, the Measures emphasise the technical-innovation and transformation value of prioritised cases, strengthen the service guarantee provided by patent agencies to requesting entities, and — notably — impose sanctions for conduct violating the principle of good faith, holding the quality bottom line.

3. Procedure-level convenience. Document requirements are streamlined to make it easier to submit requests; prioritised examination is confirmed to incur no additional fee; and processing rules address issues that practice had flagged, absorbing mature and effective existing approaches.

The filing mechanics

Requests are made electronically in XML format through the patent business-processing system (the relevant module of the system was upgraded online from 1 September 2026). For invention applications, the request must be accompanied by a statement of reasons and supporting documentation including, where applicable, the latest search report of the State Intellectual Property Office or a search report from a foreign office or international organisation, plus evidence of the status of the relevant technical field. Because prioritised examination compresses the examination timeline, the accompanying search report and prior-art material materially determine whether the case can proceed quickly once admitted.

Provincial IP offices make the recommendation for applications and re-examination cases whose first applicant is located in their province; CNIPA receives requests recommended by relevant State Council departments directly. All applicants, re-examination requesters or patentees must consent to the request. For invalidation cases, local IP administrations, courts and arbitration institutions may directly request prioritised examination from CNIPA for patents involved in their cases without provincial recommendation.

What this means for foreign applicants

  • Territorial eligibility is the gate. For patent applications and re-examination cases, prioritised examination requires the first applicant’s address to be in China — the practical route for foreign companies is filing through their Chinese subsidiary, joint venture or licensee as first applicant. Overseas applicants without a Chinese address generally cannot use this fast track for ordinary applications; they instead rely on PPH-type channels or protection-centre pre-examination where applicable.
  • A defined route for overseas and Taiwan-China-region applicants. The Fujian provincial IP authority’s guidance issued with the September 2026 implementation confirms that where overseas and Taiwan-China-region applicants do request prioritised examination, their applications must positively promote the province’s industrial upgrading and technical iteration and effectively lift regional technical capability, and the request must be submitted in paper form. This “contribution to local industry” test is the substantive threshold such applicants should prepare evidence for.
  • First-filing-in-China strategy now links to speed. Category 4 explicitly rewards applicants who first file in China and then seek substantive examination abroad on the same subject matter — a structural incentive relevant to multinationals’ global filing strategies and to their China R&D centres.
  • Good-faith discipline raises documentation standards. The new sanctions for violating good-faith principles mean requests must be supported by genuine evidence (industrialisation, infringement, or other use); speculative or mass requests designed only to jump the queue now carry reputational and procedural risk.
  • Provincial recommendation is a real step. Because provincial IP offices recommend requests, engagement with the province where the Chinese entity is registered matters; provinces with strong innovation-support policies can be expected to prioritise high-value filings aligned with their encouraged industries.

Practical steps

  • Map your China filings to the five eligibility grounds and identify which province will recommend each request.
  • For overseas entities without a Chinese first applicant, confirm the fallback route (PPH, protection-centre pre-examination) and, where provincial prioritised examination is sought, prepare the industrial-upgrade and capability-lift evidence and expect paper filing.
  • Verify that the application has not yet received a first office action before requesting prioritised examination; an application already under active examination is ineligible under the revised definition.
  • Prepare the search-report material: a CNIPA or foreign/international search report strengthens the request.
  • File electronically in XML via the patent business-processing system and watch provincial IP-office implementation guidance issued through late 2026.

Sources

  • 国家知识产权局 — 专利优先审查管理办法(局令第85号,全文): https://www.cnipa.gov.cn/art/2026/7/30/art_74_207457.html
  • 福建省市场监督管理局(福建省知识产权局)— 关于新修订《专利优先审查管理办法》施行有关事项的提示: https://scjgj.fj.gov.cn/zw/tzgg/202609/t20260904_7209087.htm
  • 央视新闻 — 国家知识产权局发布《专利优先审查管理办法》9月1日起施行: https://so.html5.qq.com/page/real/search_news?docid=70000021_2936a6b219783152

Related reading

  • see also: how patents are examined and enforced in China for foreign filers (patent-prosecution-enforcement-china)
  • see also: China’s IP protection centres and fast-track pre-examination routes (ip-protection-centre-fast-track)

专利”快车道”2026版重启:新《专利优先审查管理办法》9月1日施行

概述

2026年7月28日,国家知识产权局公布新修订《专利优先审查管理办法》(局令第85号)。该办法已于2026年7月16日经国家知识产权局第4次局务会议审议通过,自2026年9月1日起施行,2017年版《专利优先审查管理办法》(局令第76号)同时废止。优先审查是中国普通审查体系内的正式快车道——与依据双边或多边协议开展的PPH类通道、以及经知识产权保护中心预审的快速审查通道相区别——本次修订重新校准了适格条件、收紧管理并现代化了程序。对持有中国专利申请的外国申请人而言,变化影响谁能申请快车道、如何提出请求以及需要准备哪些佐证。

修订后的适用范围

依据新办法,优先审查适用于:

  • 发明专利申请:处于实质审查阶段且未作出首次处理的(首次处理指审查员已开始审查并发出通知书);
  • 实用新型和外观设计专利申请;
  • 发明、实用新型和外观设计专利申请的复审案件;
  • 发明、实用新型和外观设计专利的无效宣告案件。

明确不适用本办法的是:依据国家知识产权局与其他国家或地区专利审查机构签订的双边或多边协议开展的优先审查,以及经国家级知识产权保护中心、快速维权中心预审合格后开展的快速审查——这些按其规定处理。

五项适格情形

具有重要创新价值以及转化运用前景的专利申请、复审案件,符合下列情形之一的,专利申请人或复审请求人可以请求优先审查:

  1. 涉及新兴产业和未来产业,或者关键核心技术攻关;
  2. 涉及省级或者设区的市级人民政府重点鼓励的产业;
  3. 专利申请人或复审请求人已经产业化实施或者已经做好产业化实施准备,或者有证据证明他人正在实施其发明创造;
  4. 就相同主题首次在中国提出专利申请后,又向其他国家或地区提出实质审查请求的该中国专利申请(以中国为优先权锚点的案件);
  5. 对国家利益或者公共利益具有重大意义的其他情形。

无效宣告案件方面,涉案专利发生侵权纠纷、当事人已请求地方知识产权局处理或向人民法院起诉等情形的,无效宣告请求人或专利权人均可请求优先审查。

三大改革主题

一、调整适格条件,突出国家需求。 修订进一步聚焦服务新兴产业和未来产业领域的高质量申请;根据新修改的专利法及其实施细则调整适用范围;明确不予优先审查的情形;把制度锚定在支撑新质生产力发展、优化营商环境上。

二、全流程管理、强化质量导向。 制度上强化央地协同:国家知识产权局负责全国管理、受理并审核请求、接收国务院有关主管部门推荐的请求、加强审查资源保障;省级知识产权局负责本区域内请求的推荐,并被引导加强对请求主体的管理和精准服务。审查组织上,受理、审核、审查各环节更加规范,提高审查质量与效率。源头质量上,突出优先审查案件的技术创新和转化运用价值,强化专利代理机构对请求主体的服务保障,并首次对违反诚信原则行为实施相应罚则,筑牢质量底线。

三、优化程序与标准,提升用户体验。 完善现有技术材料提交要求,便利申请人提交请求;明确优先审查服务不收取额外费用;针对实践中反映集中的问题优化具体操作,充分吸纳成熟有效做法。

申请机制

请求须通过专利业务办理系统以XML格式电子提交(2026年9月1日起系统相关模块升级上线)。发明专利申请请求优先审查的,应附理由说明与支持性文件,包括(如适用)国家知识产权局最新检索报告或外国/国际检索报告,以及相关技术领域状况的证明。由于优先审查压缩审查周期,检索报告与现有技术材料在请求获准后能否快速推进起决定性作用。

申请与复审案件的推荐由第一申请人所在地省级知识产权局作出;国家知识产权局直接接收国务院有关主管部门推荐的请求。所有专利申请人、复审请求人或专利权人须一致同意提出请求。无效宣告案件方面,地方知识产权局、人民法院、仲裁机构可直接就涉案专利向国家知识产权局提出优先审查请求,无需省级推荐。

对外国申请人的意义

  • 地域适格是门槛。 专利与复审案件请求优先审查,要求第一申请人地址在中国境内——外国公司的现实路径是以中国子公司、合资企业或被许可方作为第一申请人提交。没有中国地址的境外申请人通常无法为普通申请使用此快车道,只能视情形依托PPH类通道或保护中心预审。
  • 境外及中国台湾地区申请人有明确通道。 福建省知识产权局随2026年9月实施发布的办理提示确认:境外及中国台湾地区申请人请求优先审查的,其专利申请应对本省产业升级、技术迭代具有积极促进作用、能有效带动辖区技术水平提升,且应当以纸件方式提出请求。”对本地产业有贡献”是此类申请人应备好证据的实质性门槛。
  • “先在中国申请”策略与提速挂钩。 第4类情形明确奖励先在中国首次申请、随后就相同主题在境外寻求实质审查的申请人——这是对跨国企业全球申请策略及其在华研发中心的结构性激励。
  • 诚信罚则提高文件标准。 违反诚信原则的新罚则意味着请求须有真实证据支撑(产业化、侵权或其他实施证据);仅为了插队而进行的投机性或批量请求将面临程序与声誉风险。
  • 省级推荐是实打实的一步。 由于请求由省级知识产权局推荐,与中国实体注册地省份的沟通至关重要;创新支持政策强的省份可望优先推荐与其鼓励产业一致的高价值申请。

实务建议

  • 把中国申请对照五项适格情形逐一梳理,确定每项请求将由哪个省份推荐。
  • 无中国第一申请人的境外主体:确认备用通道(PPH、保护中心预审);确需争取省级优先审查的,准备产业升级与能力提升证据并预期纸件提交。
  • 请求前确认申请尚未收到首次审查意见——按修订后的定义,已进入实质审查状态的申请不再适格。
  • 准备检索报告材料:国家知识产权局或外国/国际检索报告可增强请求分量。
  • 通过专利业务办理系统以XML格式电子提交,并跟踪2026年下半年各省知识产权局陆续发布的实施指引。

来源

  • 国家知识产权局 — 专利优先审查管理办法(局令第85号,全文): https://www.cnipa.gov.cn/art/2026/7/30/art_74_207457.html
  • 福建省市场监督管理局(福建省知识产权局)— 关于新修订《专利优先审查管理办法》施行有关事项的提示: https://scjgj.fj.gov.cn/zw/tzgg/202609/t20260904_7209087.htm
  • 央视新闻 — 国家知识产权局发布《专利优先审查管理办法》9月1日起施行: https://so.html5.qq.com/page/real/search_news?docid=70000021_2936a6b219783152

相关阅读

  • 见:外国申请人的中国专利审查与维权(patent-prosecution-enforcement-china)
  • 见:中国知识产权保护中心与预审快车道(ip-protection-centre-fast-track)

IP Data as a Public Resource: CNIPA and the National Data Administration’s New Opinion

  • On 24 August 2026 the China National Intellectual Property Administration and the National Data Administration jointly issued the Opinion on Strengthening the Development and Utilisation of IP Data Resources, treating IP business data generated by IP authorities as an important national public data resource.
    2026 年 8 月 24 日,国家知识产权局与国家数据局联合印发《关于加强知识产权数据资源开发利用的意见》,将知识产权管理部门履职产生的业务数据界定为国家重要公共数据资源。
  • The Opinion sets out a full-cycle governance framework — data catalogues, classification and grading, security risk assessment, a national IP data resource directory (“one ledger”), data standards and an upgraded national IP big-data centre.
    《意见》部署全生命周期治理框架:数据目录、分类分级、安全风险评估、全国知识产权数据资源目录”一本账”、数据标准体系与国家知识产权大数据中心升级。
  • On supply, it pushes government data sharing and opening, and for the first time proposes orderly licensing-operation (shou quan yun ying) of public IP data, selecting qualified operators to process data into marketable services.
    在供给端,推动知识产权政务数据共享开放,并首次提出安全有序开展知识产权公共数据授权运营,择优遴选运营机构开展市场化深度加工。
  • On application, it builds industry patent-pool databases, standard-essential patent databases and overseas-litigation databases, supports IP pledge financing and securitisation, and embeds IP data into corporate R&D, patent layout, FTO analysis and infringement warning.
    在应用端,构建产业专利池数据库、标准必要专利数据库与海外诉讼案件数据库,支撑知识产权质押融资与证券化,并将知识产权数据嵌入企业研发、专利布局、自由实施分析与侵权预警全过程。
  • Foreign companies benefit in two ways: richer, machine-readable public patent and trademark data lowers the cost of freedom-to-operate and prior-art searches in China, while authorised-operation services will offer professional-grade data products; at the same time, the emphasis on data classification and security means companies should align their own IP data governance.
    外资企业双重受益:更丰富、可机读的公开专利与商标数据降低在华自由实施与现有技术检索成本,授权运营将提供专业级数据产品;同时,数据分类分级与安全要求的强调意味着企业应同步完善自身知识产权数据治理。

IP Data as a Public Resource: CNIPA and the National Data Administration’s New Opinion | 知识产权数据资源开发利用新规:国家知识产权局与国家数据局联合意见解读

Why IP data matters now

Intellectual-property data — patent filings, trademarks, layouts, geographical indications, litigation and licensing records — has long been collected by Chinese IP authorities, but until recently it was largely siloed and under-used. On 24 August 2026 the China National Intellectual Property Administration and the National Data Administration jointly issued the Opinion on Strengthening the Development and Utilisation of IP Data Resources (the “Opinion”), which reclassifies the business data produced by IP authorities as an important national public data resource and sets out a systematic path from raw data to usable factor. The document aligns with two national agendas: the IP power-house strategy under the 2021–2035 outline, and the broader drive, led by the National Data Administration, to make public data a productive input for the digital economy.

Governance, standards and infrastructure

The Opinion’s first pillar is foundational governance. It requires sound full-lifecycle management of IP data, covering collection, storage, processing, sharing and opening; classification and grading with defined use boundaries and security requirements; and data-security risk assessment. A national IP data resource directory will be compiled to create a “one ledger” for the whole system, and provincial authorities must bring local IP data into their public-data resource catalogues. A standards system is to be developed covering basic data, data governance, development and utilisation, and security, aligned with industry standards and technical norms. On infrastructure, the National IP Big Data Centre will be upgraded as the national backbone, with regional data centres and trusted data spaces encouraged, connected into the national data infrastructure so that IP data can flow securely across regions, departments and levels. The Opinion also endorses AI, big data, cloud and blockchain applications, including industry-specific large models and public-service AI agents.

Opening supply through sharing and licensing-operation

The second pillar widens supply. IP government data will be shared proactively across departments, with “one data source for one item” (yi shu yi yuan) discipline, and linked to judicial, sci-tech, financial and market-regulatory data. Public opening is broadened through the national IP public-service platform, lowering the cost of access for all users. The most significant innovation is the proposal to conduct orderly “licensing-operation” of public IP data: selecting qualified operators to process national and local IP data into professional, market-oriented services while maintaining security and supervision. This opens a new channel through which companies can obtain curated, high-quality data products — for example clean patent landscapes or litigation analytics — without building the processing capability themselves.

Applying data across government, services and enterprise

The third pillar deepens application. For government, multi-source data supports industry patent navigation, innovation-capability assessment and the detection of abnormal applications and non-compliant agency conduct; IP data will also be connected with judicial and administrative enforcement data to strengthen coordinated protection. For services, databases for key-industry patent pools, standard-essential patents, geographical indications and overseas litigation will be built, and IP data will underpin pledge financing, securitisation and insurance, plus supply-demand matching for patent commercialisation. For enterprises — the pillar most relevant to foreign companies — IP data is to be embedded in the full R&D-to-protection cycle: tracking technology lifecycles and gaps, parsing existing patents to steer R&D, pre-application evaluation and freedom-to-operate analysis for high-value patent layouts, and patent early-warning and infringement-risk monitoring.

What foreign companies should do

For foreign-invested companies operating or innovating in China, the Opinion has three practical implications. First, search and FTO costs should fall: as patent, trademark and litigation data become more openly available in machine-readable form, freedom-to-operate and prior-art searches can rely on richer official sources, and licensed operators will offer professional data products for a fee. Second, IP-backed financing becomes more feasible: the commitment to data-enabled pledge financing and securitisation strengthens the information base for valuing IP assets in China. Third, alignment: the same classification-grading and security disciplines now applied to public IP data are a useful benchmark for a company’s own IP data governance, especially for R&D documentation, technical-secret management and cross-border data flows of IP-related data. Companies should watch the implementation guidance — including the list of authorised operators and the first tranche of sector databases — expected through the national and provincial IP authorities and data administrations in the coming months.

Sources


知识产权数据资源开发利用新规:国家知识产权局与国家数据局联合意见解读

知识产权数据为何此时受重视

知识产权数据——专利申请、商标、布图设计、地理标志、诉讼与许可记录——长期由我国知识产权主管部门归集,但过去多处于孤岛状态、利用不充分。2026 年 8 月 24 日,国家知识产权局与国家数据局联合印发《关于加强知识产权数据资源开发利用的意见》(下称《意见》),将知识产权管理部门履职产生的业务数据重新界定为国家重要公共数据资源,并给出从原始数据到可用要素的系统路径。文件对接两大国家议程:知识产权强国建设纲要(2021—2035 年)与国家数据局主导的公共数据资源开发利用部署。

治理、标准与基础设施

《意见》第一支柱是基础治理。要求健全知识产权数据全生命周期管理制度,覆盖采集归集、存储加工、共享开放等环节;加强分类分级管理,明确使用边界与安全防护要求;开展数据安全风险评估。编制全国知识产权数据资源目录,形成”一本账”;地方知识产权数据须纳入地方公共数据资源目录体系。建立覆盖基础数据、数据治理、开发利用与数据安全的标准体系,与产业标准、技术规范衔接。基础设施方面,优化国家知识产权大数据中心作为全国中枢,鼓励有条件的地方建设区域数据中心与可信数据空间,接入国家数据基础设施体系,实现跨地区、跨部门、跨层级安全流转。文件还支持人工智能、大数据、云计算、区块链等技术应用,包括行业大模型与公共服务智能体。

以共享与授权运营扩大供给

第二支柱扩大供给。知识产权政务数据将跨部门主动共享,落实”一数一源”,并与司法、科技、金融、市场监管数据互联互通。通过国家知识产权公共服务平台拓宽开放渠道,降低全社会获取门槛。最具创新性的安排是提出安全有序开展知识产权公共数据授权运营:择优遴选运营机构,对国家与地方知识产权公共数据做市场化深度加工,在安全监管下提供专业服务。这为企业在不自建加工能力的情况下获得高质量数据产品(如干净的专利全景或诉讼分析)开辟了新通道。

应用:政府、服务与企业

第三支柱深化应用。政府端,多源数据支撑产业专利导航、创新能力评估与非正常申请、违规代理线索排查;知识产权数据与司法裁判、行政执法数据互通,强化协同保护。服务端,建设重点产业专利池数据库、标准必要专利数据库、地理标志专题数据库与海外诉讼案件数据库;以数据融合支撑知识产权质押融资、证券化与保险,以及专利转化供需匹配。企业端——与外资企业最相关——将知识产权数据嵌入研发、转化、保护全过程:技术生命周期分析、专利动态追踪与空白点研判,关键专利解析以确定研发路径,申请前评估与自由实施分析支撑高价值布局,专利预警与侵权风险监测维护合法权益。

外资企业应做什么

对在华经营或创新的外资企业,《意见》有三重实务意义。第一,检索与自由实施成本应下降:专利、商标与诉讼数据以可机读形式更开放后,FTO 与现有技术检索可依托更丰富的官方来源,授权运营商将提供付费专业数据产品。第二,知识产权融资更可行:数据支撑的质押融资与证券化承诺强化了在华知识产权资产估值的信息基础。第三,对标治理:公开知识产权数据适用的分类分级与安全纪律,可作为企业自身知识产权数据治理(研发文档、技术秘密管理、涉知识产权数据跨境流动)的有益基准。企业应关注后续实施配套——授权运营机构名单与首批行业数据库——预计将由国家和省级知识产权、数据管理部门在未来数月陆续推出。

Sources

China’s Revised Integrated Circuit Layout Design Regulations: Protection, Registration and Implications for Foreign Chip Designers

  • On 23 July 2026 the State Council promulgated the revised Regulations on the Protection of Integrated Circuit Layout Designs (State Council Order No. 842), the first systematic revision in more than 20 years, effective 15 October 2026.
    2026 年 7 月 23 日国务院公布修订后的《集成电路布图设计保护条例》(国务院令第 842 号),这是该条例 20 余年来首次系统性修订,自 2026 年 10 月 15 日起施行。
  • The revised Regulations extend protection to layout designs of integrated circuits with photonic, quantum and other emerging functions, closing a gap that mattered as chip designs move beyond conventional CMOS processes.
    修订后的条例将集成光子、量子等功能的集成电路布图设计纳入保护范围,弥补了芯片设计迈向传统 CMOS 工艺之外时出现的保护空白。
  • Registration is now anchored in good faith: applications must be based on genuine creative activity, a declaration of originality is required, clearly non-compliant applications are rejected, and rights lost through force majeure or other justified grounds can be restored.
    登记制度以诚信为锚:申请须基于真实创作活动,须提交独创性声明,明显不符合规定的申请将被驳回,因不可抗力等正当事由延误期限导致权利丧失的可请求恢复。
  • Infringement compensation is strengthened: damages follow the right holder’s actual loss or the infringer’s gains, reasonable multiples of the licence fee where these are hard to determine, and punitive damages apply to intentional infringement with serious circumstances.
    侵权赔偿力度加大:赔偿额按权利人实际损失或侵权人获利确定,难以确定的参照许可使用费倍数合理确定,故意侵权且情节严重适用惩罚性赔偿。
  • The scope of the protected layout design is defined by the registered reproduction or drawings, with the originality declaration usable to interpret originality — bringing China’s regime closer to international practice.
    受保护布图设计范围以登记的复制件或图样为准,独创性声明可用于解释布图设计的独创性——使中国制度进一步贴近国际实践。
  • For foreign chip designers, the revision matters because foreign nationals and enterprises whose layouts are first commercially exploited in China, or whose states have an agreement or common treaty with China, enjoy protection under the Regulations — the rules on foreign rights-holders and on transfers, licensing and pledge registration have all been modernised.
    对外国芯片设计企业,本次修订意义重大:首先在中国境内商业利用其布图设计的外国人、外国企业,或其所属国与中国签订协议或共同参加国际条约的,可依条例获得保护——关于外国权利人以及转让、许可、出质登记等规则均已现代化。

China’s Revised Integrated Circuit Layout Design Regulations: Protection, Registration and Implications for Foreign Chip Designers | 中国修订后的集成电路布图设计保护条例:保护、登记与对外国芯片设计企业的影响

The context and what changed

The Regulations on the Protection of Integrated Circuit Layout Designs (State Council Order No. 300 of 2001) were revised by the State Council on 23 July 2026 under Order No. 842, following adoption at the 91st executive meeting of the State Council on 10 July 2026, and take effect on 15 October 2026. This is the first systematic revision in more than two decades. The revision was driven by three forces: the rapid development of integrated-circuit technology and industry, the need to bring practice-proven measures up to administrative-regulation level, and alignment with other Chinese IP laws and with international treaties. The new text modernises registration procedures, sharpens the definition of the protected layout design, strengthens infringement remedies and adds provisions on the exploitation of layout designs. For a foreign chip designer, the most practical question is how these changes affect filing a Chinese registration, defending the design against copying, and exploiting it through transfer or licensing.

Extended subject matter: photonic and quantum circuits

The most forward-looking change is the express extension of protection to layout designs of integrated circuits “with photonic, quantum and other functions”. As conventional transistor processes approach physical and manufacturing limits, photonic chips (which route light rather than electrons) and quantum processors are emerging, and their design activity increasingly lies in the arrangement of waveguides, qubits and interconnects — precisely the kind of three-dimensional configuration that a layout-design regime is meant to protect. The revision removes the risk that a cutting-edge design falls outside the statutory subject matter because it is not a “semiconductor-based” circuit in the traditional sense. For foreign firms developing photonic or quantum designs, this is a meaningful expansion of the protected subject matter in China and should be reflected in IP strategy.

Registration in good faith

The revised Regulations tighten the integrity of registration. Applications must be based on genuine creative activity and may not be fabricated; a declaration of originality is required and the submitted reproduction or drawings must clearly show the original parts; applications that are obviously non-compliant are rejected; after registration, any person may request revocation where the registration should not have been granted, and a revoked registration is treated as if the exclusive right never existed; and where rights are lost because the applicant missed a prescribed period due to force majeure or other justified reasons, the right may be restored on application. These provisions mirror the integrity requirements of the patent and trademark systems and give examiners and courts a cleaner basis for policing false claims of authorship.

Scope of protection and infringement remedies

Under the revision, the protected layout design is defined by the registered reproduction or drawings; the originality declaration may be used to interpret originality. This is a significant clarification: previously the boundaries of the protected design could be contested at length; now the registration record itself fixes the reference. On remedies, the Regulations now provide: damages are calculated by the right holder’s actual loss or the infringer’s gains; where these are hard to determine, a reasonable multiple of the licence fee may be used; for intentional infringement with serious circumstances, punitive damages apply (consistent with the Civil Code); and the compensation includes the right holder’s reasonable expenses in stopping the infringement. A good-faith acquirer who bought and commercially exploited a chip containing an infringing layout without knowing is not treated as an infringer, but after receiving notice may continue to use existing stock or prior orders upon payment of a reasonable fee.

Exploitation: transfer, licensing, pledge and rewards

The revised Regulations add provisions promoting the exploitation of layout designs. The IP administrative authority under the State Council must, with other departments, take measures to strengthen public services and promote exploitation. Where a legal person or unincorporated organisation organises the creation of a layout design, it should, in accordance with the Law on Promoting the Transformation of Scientific and Technological Achievements and other rules, give reasonable rewards and remuneration to qualifying personnel. Rules on assignment, licensing, pledge registration and the exercise of rights by co-owners are modernised. For foreign licensors, the modernised transfer and pledge provisions mean that a Chinese subsidiary or licensee can register security interests over layout-design rights, and that licence arrangements have clearer statutory footing.

How foreign parties are protected

The nationality provisions are preserved: Chinese natural persons, legal persons and other organisations enjoy protection under the Regulations; foreigners, foreign enterprises and other foreign organisations whose layout designs are first commercially exploited in China enjoy protection; and foreigners whose states have signed an agreement with China on layout-design protection, or which participate with China in a relevant international treaty, also enjoy protection. Under reciprocity provisions, where a foreign state or region takes discriminatory prohibitive or restrictive measures against China in layout-design protection, China may take corresponding measures against that state or region. For a foreign designer, the practical route is to file a registration with the IP authority (through the electronic system), typically via a Chinese patent agency or a local subsidiary; the registration application and fee system are administratively light compared with patents.

What foreign chip companies should do now

First, audit current layouts: designs already in commercial use in China but unregistered can be registered before the Regulations take effect, and designs newly commercialised after 15 October 2026 should be registered promptly. Second, for photonic and quantum designs, confirm eligibility under the expanded subject matter and register them to secure priority dates. Third, review supply-chain and licensing documentation: update licence agreements to reflect the modernised transfer, pledge and reward rules, and check that Chinese subsidiaries hold the registrations for designs they exploit locally. Fourth, update internal records to satisfy the good-faith registration requirements — genuine creative activity documentation and originality declarations will now be expected. Fifth, where disputes arise, note that the strengthened damages and punitive-damages provisions apply, and that administrative enforcement through the IP authority remains a first-line option alongside litigation. The 2001 Regulations served the industry well for two decades; the 2026 revision is designed to keep China’s layout-design protection credible as the industry moves into photonic and quantum territory.

Sources


中国修订后的集成电路布图设计保护条例:保护、登记与对外国芯片设计企业的影响

背景与变化

《集成电路布图设计保护条例》(2001 年国务院令第 300 号)经 2026 年 7 月 10 日国务院第 91 次常务会议审议通过修订,2026 年 7 月 23 日以国务院令第 842 号公布,自 2026 年 10 月 15 日起施行。这是该条例 20 余年来首次系统性修订。修订由三股力量推动:集成电路技术与产业的快速发展、把实践证明行之有效的做法上升为行政法规、以及与国内其他知识产权法律和国际条约的衔接。新文本现代化了登记程序、锐化了受保护布图设计的界定、强化侵权救济,并新增促进布图设计运用的条款。对外国芯片设计企业,最实际的问题是新规如何影响在华登记、对抗仿制,以及通过转让或许可进行运用。

扩展客体:光子与量子电路

最具前瞻性的变化是明确将”集成光子、量子等功能的集成电路的布图设计”纳入保护范围。随着传统晶体管制程逼近工艺与物理边界,光子芯片(以光而非电子传输信号)与量子处理器兴起,其设计活动日益集中于波导排布、量子比特与互连的三维配置——这正是布图设计制度所拟保护的三维构型。修订消除了前沿设计因非传统意义上的”半导体基片”而落入客体之外的隐患。对开发光子或量子设计的外国企业,这是中国受保护客体的一次实质性扩展,应反映在知识产权战略中。

诚信登记

修订后的条例收紧登记诚信。申请应当以真实创作活动为基础,不得弄虚作假;须提交独创性声明,提交的复制件或图样应清楚显示独创部分;明显不符合规定的申请应当驳回;登记后任何人发现登记不符合规定可请求撤销,被撤销的专有权视为自始不存在;因不可抗拒事由或其他正当理由延误期限致权利丧失的,可请求恢复权利。这些规定与专利、商标制度的诚信要求相衔接,为审查与司法打击虚假作者主张提供了更清晰的依据。

保护范围与侵权救济

修订后,受保护的布图设计以登记的复制件或图样所显示的为准,独创性声明可用于解释布图设计的独创性。这是重要澄清:此前保护边界可被长期争辩,如今登记档案本身固定参照系。救济方面,条例现规定:赔偿额按权利人实际损失或侵权人获利确定;难以确定的,参照许可使用费倍数合理确定;故意侵权且情节严重适用惩罚性赔偿(与民法典衔接);赔偿还包含权利人为制止侵权行为所支付的合理开支。不知情且无合理理由应知而购入并商业利用含侵权布图设计芯片的善意取得者不视为侵权,但收到明确通知后可继续利用现有存货或此前订货,并应支付合理使用费。

运用:转让、许可、出质与奖酬

修订后的条例新增促进布图设计运用的条款。国务院知识产权行政部门应会同有关部门加强公共服务、促进布图设计运用。法人或非法人组织主持创作布图设计的,应依促进科技成果转化法等对符合条件人员给予合理奖励和报酬。转让、许可、出质登记与共有人权利行使规则实现现代化。对外国许可人,现代化后的转让与出质条款意味着中国子公司或被许可人可就布图设计权登记担保权益,许可安排的法定基础更清晰。

外国当事人如何受保护

国籍条款保留:中国自然人、法人和其他组织依条例享有专有权;首先在中国境内投入商业利用的外国人、外国企业和其他外国组织享有专有权;所属国与中国签订保护协议或共同参加相关国际条约的外国人享有专有权。依对等条款,外国国家或地区在布图设计保护方面对中国采取歧视性禁止、限制等类似措施的,中国可采取相应措施。对外国设计者,实务路径是向国务院知识产权行政部门申请登记(通过电子系统),通常经由中国专利代理机构或本地子公司办理;登记申请与缴费体系较专利更轻。

外国芯片企业现在应做什么

其一,审计现有布图设计:已在中国商业利用但未登记的设计,可在条例生效前补办登记;2026 年 10 月 15 日之后新商业利用的设计应及时登记。其二,光子与量子设计:按扩展客体确认适格并尽早登记锁定申请日。其三,审阅供应链与许可文件:按现代化后的转让、出质与奖酬规则更新许可协议,确认中国子公司持有所在区域利用设计的登记。其四,更新内部记录以符合诚信登记要求——真实创作活动文件与独创性声明将成为审查预期。其五,发生争议时注意强化后的损害赔偿与惩罚性赔偿条款,并记得知识产权行政部门的行政保护仍是与诉讼并行的第一线选项。2001 年条例为产业服务了二十余年;2026 年修订的设计意图是让中国布图设计保护在产业迈向光子与量子时代时继续保持可信。

Sources